Microtechnologies for Cardiovascular Tissue Engineering by Eng, George
  












Submitted in partial fulfillment of the 
Requirements for the degree of 
Doctor of Philosophy 























Microtechnologies for Cardiovascular Tissue Engineering 
George Eng 
Cardiovascular disease is a rising epidemic worldwide, and curative therapies remain 
elusive. Heart and vascular disease remain some of the hardest to cure due to the limited capacity 
of the heart to repair itself, necessitating a cell or organ based therapy to cure the inevitable 
descent into heart failure. Tissue engineering is uniquely poised to significantly alter this disease 
burden though the fabrication of cardiac and vascular tissues in vitro. However, the challenges 
for achieving these aims are significant - for cardiac tissues, the therapy must adhere to strict 
requirements of adequate perfusion and functional integration with the damaged heart. Vascular 
tissues are required to be amenable to surgical anastomosis while at the same time provide 
nutrient transport on the cellular level. Recently, a new set of technologies based from the 
semiconductor industry, have enabled micron level control over the cellular environment and 
cells themselves and may enable novel approaches to fulfill these tissue engineering 
requirements.  In this dissertation, these microtechnologies will be leveraged to address some of 
the current obstacles that limit the use of tissue engineering approaches for functional therapy. 
Specifically, microtechnologies were used to screen the effect of electrical stimulation on the 
function and maturation of human embryonic stem cell derived cardiomyocytes, which resulted 
in the ability to program specific individual beating frequencies of the cells while improving 
contractile function and led to the identification of a channel specific effect for frequency 
modulation. These technologies were also used to distinguish the vasculogenic potential of 
different mesenchymal stem cell sources for nascent vessel stabilization, and enabled the 
development of a powerful hydrogel docking platform with the novel capability to spatially 
pattern any number of cells, cytokines or drugs on the microscale, while permitting scale up for 
 larger tissue generation without the loss of precision. Finally, these technologies were used to 
create vascular networks with hierarchical branching patterns that could be implanted and used 
in vivo fulfilling a major criterion of vascular tissue function – surgical compatibility with 
microscale architecture for tissue perfusion. Therefore, these microtechnologies support novel 
interrogation of cell function and enable new methods to engineer cardiovascular tissues.  
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with MSCs, but not with UCV and UCA cells. Fluorescent microscopy, 
scale bar 500 μm. .......................................................................... 67 
Figure IV-6. The progression of cell sprouting in the hydrogel co-culture system. 
A) Co-culture of HUVECs with bone marrow MSCs encapsulated 
within the separate channels at a 500 μm distance. Bright-field images 
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staining shows von Willebrand factor positive HUVECs (b). Scale bar: 
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Figure V-1. A library of hydrogel shapes. Bright field images of 36 additional 
shapes are shown to demonstrate potential geometries and thus species 
that can be patterned. The English alphabet was chosen as a simple and 
easily recognizable set of distinct and mutually exclusive shape 
geometries. These additional shapes were designed to maintain mutual 
exclusivity with all other shapes. If more than 36 species need to be 
patterned, many other shape geometries can be designed. Scale bar: 200 
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Figure V-2. Engineering of geometrically defined cellular microenvironments by 
docking shape-coded hydrogels into hydrogel templates. (a) 
Schematic of micromolding approach to fabrication of gelatin 
methacrylate (GelMA) hydrogel. (b-e) Bright field microscopy images 
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docking into congruent template wells. (g,h) Merged fluorescent images 
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congruent wells after sorting. (i,j) Specificity of shape sorting as a 
function of shape geometry, the number of sorting cycles (1-10) and the 
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and (j) 85%. (k) Yield of sorting (the percentage of wells correctly 
filled), as a function of rounds of shaking for three shape geometries. 
Scale bars represent 300 µm. Data are shown as Average ± SD (n=20).
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methacrylate hydrogels. (a) Elastic and (b) equilibrium modulus of 5, 10, 
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0.9894. (c) and (d) Sorting specificity and efficiency for different shapes 
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standard deviation from the mean. Two-way ANOVA comparing 
different gel percentages and different shape geometries at each round of 
shaking yielded no significant differences between groups (n=3, 
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hydrogel shapes. (a-d) Time lapse images of sorted circles and 
rectangles dosed with 100 µg/mL Texas-Red tagged 10 kDa dextran and 
100 µg/mL Alexa-488 tagged 10 kDa dextran respectively. Scale bars: 
600 µm. (e) Fluorescent intensities were obtained starting from the circle 
edge and to a distance of 2 mm from the circle edge for five different 
time points. Intensities were normalized to the maximum intensity 
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tagged 10 kDa dextran was plotted as a function of distance from the 
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encapsulated within GelMA rectangles after 4 days of cultivation. 
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regions outlined by the white rectangles in (j,l) Scale bars: 300 µm. (n) 
Confocal microscopy of actin (green) and DAPI (blue) staining of MSC 
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w/v GelMA respectively. Time lapse images of sorted circles dosed with 
Texas-Red tagged BSA were taken at 10 minute intervals for 100 
minutes. Relative fluorescence intensity was plotted as a function of 
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point, the distance to 50% intensity was determined and plotted as a 
function of time. These fit a linear curve with R2 of 0.9362 and 0.9918. 
The higher slope for the 10% w/v GelMA diffusion suggests a higher 
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in response to concentration gradients generated by ECs. (b,c) Cell 
vectors were generated from Day 14 phase contrast cell images using 
image processing techniques. Average migration rates were measured 
using the vectors generated for each group. (d,e) Representative 
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PROMISE OF CARDIOVASCULAR TISSUE ENGINEERING  
Cardiovascular disease is the leading cause of death worldwide
1, 2
. In the United States 
cardiovascular diseases account for approximately 30% of all deaths, with cardiovascular disease 
population constantly increasing. In 2008 alone, 86.2 million Americans were living with some 
form of cardiac disease, and this number is projected to grow to 40.5% of the American 
population by the year 2030. Concomitantly, the financial burden of disease is also projected to 
rise, from present estimates of $300 billion to $800 billion
3
. On a global scale, cardiovascular 
disease is responsible for 60% of deaths, and will become increasingly important as global 
obesity and malnutrition continue to rise. Importantly, cardiovascular disease is responsible for 
80% of non-communicable diseases in low and middle income countries, with grave social and 
economic consequences.  
Unfortunately, despite this epidemic of increasing amounts of cardiovascular disease, the 
body has very limited capacity to repair itself compared to other tissues. For instance, once a 
section of the myocardium is infarcted, scar forms and the myogenic potential of that area is lost. 
Present curative therapies are limited to transplantation, and due to the huge incidence of heart 
disease, replacement organs are always in short supply, with many patients dying while waiting 
for a new organ.  
The vasculature, the other primary component of the cardiovascular system also can be 
fragile and directly related to heart failure. The constant narrowing of the vessels used to feed the 
heart, atherosclerosis, can be mitigated by coronary artery stenting and coronary artery bypass 
grafting, but after an initial graft, many patients require re-operation, but lack the native vessels 
to support cardiac function.  
A potential solution therefore is to fabricate and grow these critical organ and tissues in 
the laboratory to fulfill this need, and ameliorate this ever increasing burden of disease occurring 
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on a global scale. Tissue engineering is therefore poised to provide potentially curative therapies 
in the disease with the highest incidence in the world and which will only become a greater 
problem with the further development of the world. Despite this immense need, efforts to 
generate artificial tissues in vitro have not yielded major clinical applications for cardiovascular 
disease. Part of the reason behind this is the particularly difficult environment and requirements 
of the tissues engineered constructs would replace. Cardiac tissues have one of the highest 
metabolic demands in the body, and an appropriate cell source has only recently been identified. 
Functional vasculature has been difficult to form due to thrombotic complications in small 
diameter vessels, where minute problems in flow architecture and elastic compliance can lead to 
intimal hyperplasia and occlusion.  
  
MICROTECHNOLOGIES 
Microtechnolgies -the ability to manipulate cells, cytokines and extracellular matrix on 
the micron level - can provide unique approaches to improve the study of cardiovascular tissue 
engineering. These methods have been developed from the semiconductor industry to manipulate 
and miniaturize electronics, but have reached and surpassed the micron scale in resolution. This 
size scale is on the order of individual cells, and this exquisite control may enable unique studies 
and engineering methods to be leveraged to create novel systems for cardiovascular tissue 
engineering. The limitations in existing techniques to assemble and properly organize cardiac 
tissues could be enhanced through micro-scale positioning, and fluid flows can be directly 
tailored to design specific vessel geometries to enhance nutrient transport. Another attractive 
feature of these technologies is the inherent miniature scale, which minimize the use age of 
costly biological signaling agents, while providing much higher throughput systems to screen 
many more conditions than can be studied through conventional tissue culturing methods.   
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HYPOTHESIS 
Therefore, the proposed hypothesis is that microtechnolgies can enable improved 
cardiovascular tissue engineering through microscale precision in controlling the local 
microenvironment and high throughput screening for optimal growth and stimulation conditions. 
 
SPECIFIC AIMS 
This dissertation aims at the use of microtechnolgies to study multiple facets of 
cardiovascular tissue engineering. The five specific aims will be divided based on a simple 
hierarchical size scale of the desired cellular interactions.  
 
Aim 1: Electrical Conditioning of Human Embryonic Derived Cardiomyocytes 
Development of methods for cardiomyocyte (CM) differentiation from human stem cells 
has enabled patient specific cardiac disease models and increased the promise of clinical 
application of cardiac tissue engineering for treating myocardial infarction. One major obstacle, 
however, is to mature the relatively nascent CMs and direct their functional assembly. 
Mimicking native development we hypothesized that induction of synchronous contractions by 
electrical stimulation will enhance the maturation and assembly of immature human CMs, 
similar to the functional improvements found when external field stimulation was applied to rat 
neonatal cardiomyocytes. However, due to the wide range of stimulation paradigms, a 
microbioreactor system was developed to test multiple electrical field conditioning regimes, 
providing a relatively high throughput platform to initially study the conditioning of human 
embryonic derived cardiomyocytes.  In this specific aim, our goal is to characterize the effect 
and potentially determine a mechanism of external field stimulation on the functional properties 
of hESC derived cardiomyocytes through the use of a high throughput multiwell reactor system. 
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Aim 2: Micropatterned Three-Dimensional Hydrogel System to Study Human Endothelial-
Mesenchymal Stem Cell Interactions 
The creation of vascular networks to support cardiac tissue is a major challenge of tissue 
engineering. While it is known that endothelial and mural vascular cells are integral to the 
formation of stable blood vessels, the specific cell type and optimal conditions for engineered 
vascular networks are poorly understood. Therefore this specific aim will utilize a 
micropatterning approach to quantify and investigate the vasculogenic potential of various 
sources of MSC mural cells as they interact with endothelial cells.  We isolated three populations 
of MSC’s derived from (i) bone marrow aspirates, (ii) perivascular cells from umbilical cord 
vein, and (iii) perivascular cells from umbilical cord artery. Cell populations were isolated and 
identified as MSCs according to their phenotypes and differentiation potential. Human umbilical 
cord endothelial cells (HUVEC) were used as a standard for endothelial cells. A novel co-culture 
system was developed to study cell-cell interactions in a spatially controlled three-dimensional 
(3D) fibrin hydrogel model. Using microfluidic patterning, it is possible to localize hydrogel-
encapsulated HUVECs and MSCs within separate channels spaced at 500, 1000 or 2000 μm, and 
we will use this spatially defined linear culture to study the vasculogenic and migratory effects of 
these MSC’s. 
 
Aim 3: Assembly of Complex Cell Microenvironments Using Geometrically Docked 
Hydrogel Shapes 
Though the previous aim investigated the vasculogenic potential for different MSC types, 
we also wanted to develop a more general system which could allow for broad control over the 
three dimensional cell microenvironment, with the capacity to recapitulate varied spatial and 
temporal multicellular culture.  Attempts to engineer cell microenvironments have been limited 
in their ability to faithfully recapitulate this complicated cell organization. We aim to develop a 
method of assembling cellularized micro-hydrogel shapes as fundamental building blocks, to 
construct complex cellular microenvironments, where each block can contain any concentration 
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of cells or cytokines, and can be placed into any spatial configuration, providing extensive 
compositional tunability. We aim to engineer migratory growth patterns of human mesenchymal 
stem and endothelial cells using precisely arranged hydrogel shapes and model the heterotypic 
interactions between cell types were used to establish a finite element diffusion model, predicting 
a spatial map of cell migration. We expect that this platform will enhance our understanding of 
cell interactions, ultimately aiding in the design and fabrication of cardiovascular tissues, 
incorporating stereotypical tissue architecture and complex cell components to provide added 
functionality. 
 
Aim 4: Tubular Silk Scaffolds for Small Diameter Vascular Grafts 
As described in the introduction, the major cause of cardiac injury is myocardial 
infarction, which is initiated via coronary artery disease, an inflammatory narrowing of the 
vessel lumen. The heart is particularly susceptible to this narrowing since its metabolic demands 
are high; therefore, potential cardiac therapies should be designed to address this prevailing 
cause of cardiac failure. In general, small diameter vascular grafts are currently unavailable for 
microvascular surgeries, as approaches using synthetic sources have been unsuccessful in 
producing non-thrombogenic grafts with inner diameters less than 6 mm. Here we aim to use a 
microscale textile weaving approach to fabricate silk fibroin as a microvascular graft material 
and report on the production and application of silk tubes that demonstrate improvement over 
existing vascular graft materials. Silk material properties will be assessed in vitro in terms of 
thrombogenicity (thrombin and fibrinogen adsorption, platelet adhesion) and vascular cell 
response (endothelial and smooth muscle cell attachment and proliferation) in comparison with 
polytetrafluoroethylene (PTFE), a synthetic material currently used for vascular grafts. 
Concurrently, silk tubes will be tested in vivo in the abdominal aortas of Sprague-Dawley rats. 
Outcomes in vivo will be assessed at different time points through gross observation (acute 
thrombosis, patency) and histological staining (H&E, Factor VIII, smooth muscle-actin). 
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Establishing silk as a potential surrogate for micro-sized vascular grafts will be a significant step 
in establishing a bridge to study and support cardiovascular tissue functions. 
 
Aim 5: Hierarchically Designed Blood Vessels 
With the establishment of an interposition abdominal aorta microvascular graft model in 
aim four, this aim intends to develop a vascular network which can better supply the cardiac 
graft with nutrient transport both in vitro and in vivo. To create this functional cardiac tissue with 
a complex vascular branching network, microfabrication technologies will be used to pattern 
microfluidic channel within the graft material for fluid flow. The hierarchically organized 
vascular network of blood vessels will branch from relatively large (millimeters in size) to very 
small (10 µm in size) conduits and will be subject to a set of biophysical cues which will instruct 
the cells to grow functional vascular tissue.  
Microfabrication technologies allow for the spatially precise creation of a cell-instructive 
environment for the formation of vasculature which can be made in any geometry and for our 
studies we envision testing multiple vascular branching designs. With the underlying architecture 
of vasculature made, cardiac tissue will be grown around the vessel conduits, using a hydrogel 
encapsulation method. Bioreactors will provide biophysical signaling using a time varying fluid 
flow regime to mature the blood vessels along with angiogenic cytokines to induce individual 
capillary sprouting into the cardiac tissue regions, providing transport at the cellular scale. This 
hierarchical design is particularly important because it creates a specific inlet and outlet for 
simple cannulation in vitro, or clear ends for surgical anastomosis in vivo, while maintaining a 
microvascular network for efficient nutrient delivery and waste removal. This design bridges the 
gap between larger scale singular vascular tubes which often lack effective transport to 
individual cells, and co culture studies with endothelial cells which lack fluid perfusion. The 
vascular functionality of the cardiac graft will be assessed in vivo using the network in as an 




Background, Problem, Current Techniques 
Aim 1: Electrical Conditioning of Human Embryonic Stem Cell Derived Cardiomyocytes 
Over the past few years, the cardiovascular potential of hESCs has been thoroughly 
investigated, with major advances in demonstrating differentiation of these cells into vascular, 
smooth muscle and cardiomyocyte populations
4-7
. This specific induction
4
 was achieved by 
mimicking the signals found during embryonic development exposing hESCs to these cytokines 
to produce three distinct mesoderm-derived populations. The cardiac specific lineage was 
characterized by two mesoderm markers, KDR, and PDGFRa, and if quantified, provide reliable 
indicators for the generation of cardiomyocytes (Fig II-1).  These markers were chosen due to 
similar studies isolating cardiovascular progenitors which from the mouse embryo using the 
homologous mouse proteins. This methodology, refined to maximize the presence of defined cell 
subpopulations, has been also used to generate cardiomyocytes from human iPS cells.  
A substantial (66%) KDR low, PDGFRa negative population was detected in 5-day-old 
hESC-derived embryoid bodies (EBs) when induced with appropriate concentrations of activin 
(6ng/ml) and BMP-4 (10ng/ml).  When isolated (by cell sorting) and cultured as a monolayer, 
the KDR low, PDGFRa negative cells (K+P+) generated a population highly enriched for 
cTNT+ cardiomyocytes (>80%) following 9 days of culture. The smaller KDR+PDGFR neg 
population (11%) displayed no cardiac potential, but did generate hematopoietic progeny (not 
shown). Under these conditions, cell sorting is no longer critical, as the unsorted population 
generates a high enough percentage of cells to potentially be used for cardiac tissue engineering 
purposes.  The ability to monitor cardiac mesoderm induction by co-expression of KDR and 
PDGFRa provides an easy method for optimizing the differentiation conditions for both hESC 
and hiPSC lines.   
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Figure II-1 KDR and PDGFR-α Are Expressed on Cardiac Mesoderm Generated from 
hESCs (A) Induction of K+P+ populations in day 5 EBs with varying concentrations of BMP4 
and activin. All cultures contain bFGF (5 ng/ml). Numbers represent percentage of cells in each 
gate.(B) Percent of CTNT+ cardiomyocytes at day 20 of culture in EBs induced with factor 
combinations corresponding to those shown in (A).(C) Expression (qPCR) 
of MESP1 and NKX2.5 in EBs at the indicated days after induction with activin 6 ng/ml and 
BMP4 10 ng/ml. Error bars indicate the SD of the mean from six experiments. Primer sequences 
are listed in Table S2.(D) SMA and CTNT expression in day 18 EBs induced with activin 
6 ng/ml and BMP4 10 ng/ml.(E) Cardiac potential of isolated K+P+ cells or whole EB-derived 
cells cultured as monolayers in cardiac conditions. HES2 hESCs derived with activin 6 ng/ml 
and BMP4 10 ng/ml were analyzed for CTNT after 9 days of monolayer culture.(F) Fluorescent 
microscopy of a monolayer generated from sorted K+P+ cells, stained with antisarcomeric α-
actin (red) and dapi (blue). Adapted from: Cell Stem Cell. 2011 Feb 4;8(2):228-40. 
Previously work done by Radisic et al has pioneered the application of bioreactors with 
electrical stimulation for directed cell differentiation and assembly into functional tissue 
structures
8
. Electrical stimulation alone caused upregulation of cardiac markers and substantially 
enhanced the alignment, coupling, and contractile ability of immature (neonatal rat) 
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cardiomyocytes. Interestingly, the measured differences suggested cell maturation. ESC-CMs 
express Cx-43 (a protein necessary for functional gap junctions) and a-MHC (a protein necessary 
for the contractile apparatus). However, the high initial expression levels of Cx-43 (by day 6) 
and a-MHC (by day 13) tend to decline with time, suggesting the need for biophysical regulation 
to maintain and mature the cardiomyocyte functionality.  
On ongoing problem in the field is the maturation and electrical integration of a human 
cardiomyocyte cell source. There has been some studies showing maturation of human derivied 
cardiomyocytes, but their functional maturation in vitro has been limited compared to the 
requirements needed in the failing heart
9, 10
. Therefore methods are needed to help enhance this 
functional assembly of this nascent cell source. The cells are required to couple together and 
even create a mechanically robust section of tissue to fully repair a thick myocardial infarction. 
A further problem, even is the cells were functionally assembled is electrical integration of the 
therapeutic cells with the host tissue
11
. Many critics have suggested that the addition of 
unmatched cardiomyocytes grown in culture could lead to foci of arrhythmia when implanted. 
This is particularly true when one considers the harsh environment of the infarcted heart, with 
fibroblast overgrowth, scar formation limits the electrical connectivity possible, which could lead 
to worse outcomes for transplanted cells or tissues when used in the diseased heart.  
Present techniques to address this issue have looked into the basic antiarrythmigenic 
properties of hESC and iPSC cells when implanted in a Guinea pig heart model
12
. It has been 
shown that the addition of these cells even in arrythmogenic prone diseased tissue can provide a 
protective function reducing the incidence of arrhythmias due to the natural pacemaker plasticity 
of the stem cell derived cardiomyocytes
12
. Histology showed functional integration and relatively 
uniform spatial distribution of the implanted cells within the host myocardium, with proper 
expression of cardiac specific markers to exlude the possibility of other cell type proliferation. 
The hESC CM group improved cardiac function through fractional shortening, and had a greatly 
reduced risk for spontaneous ventricular tachycardia. When challenged with induced ventricular 




Figure II–2 a, b, Twenty-eight-day-old hESC-CM grafts in a cryoinjured heart stained with 
picrosirius red (a), and anti-β-myosin heavy chain (βMHC, red) plus human-specific in situ 
probe (HumCent, brown) (b). c–h, Confocal image of host–graft contact, dual-labelled for 
HumCent (white) and βMHC (red) (c; a higher magnification image of the area in the white box 
in c is shown in d), de-stained and then immunostained for βMHC (red) and either connexin 43 
(Cx43, green; e and g) or cadherins (green; f and h). Arrows indicate Cx43 and cadherin shared 
between graft and host myocytes. i, Left-ventricle fractional shortening (FS) by 
echocardiography in uninjured animals and cryoinjured recipients of PSC vehicle only, non-CMs 
or hESC-CMs at 2 days prior to and 28 days after transplantation (Tx). j, Representative 
telemetric ECGs, including non-sustained ventricular tachycardia (VT) in an hESC-CM recipient 
(top trace), as well as sustained VT and triplet PVCs in a non-CM recipient (bottom trace). k, 
Percentage of animals by group that showed spontaneous VT during monitoring from days 3 to 
28 after transplantation. l, Frequency of spontaneous VT by group. m, ECG (red) and stimulation 
(blue) traces from a cryoinjured non-CM recipient induced to sustained VT by PES. n, 
Percentage of animals in each group induced to VT. All data are presented as mean ± s.e.m.; n ≥ 
13 per group. NS, not significant. *P < 0.05; **P < 0.01. †P < 0.05 versus day −2. Adapted from 
Nature. 2012 Sep 13;489(7415):322-5 
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a very large decrease in the frequency of induced ventricular tachycardia. However a primary 
limitation of this work is the fact that control and modulation of this intrinsic anti-arrythmogenic 
capacity was mostly unalterable, so this same relative dosage over a larger animal might not have 
similar results. This really highlights the need for a system to control the intrinsic electrical 
signals of cells to be used therapeutically.  
 
Aim 2: Micropatterned Three-Dimensional Hydrogel System to Study Human Endothelial-
Mesenchymal Stem Cell Interactions 
Vascularization is critical in the maintenance of healthy, viable cardiac tissue due to 
increased metabolic demand of this tissue compared to many others. Additionally microvessel 
disease is caused by many of the same disease pathways that involve heart failure, namely 
diabetes. This microvascular disease is at least partially exemplified by a reduction in the 
vascular responsiveness of nascent blood vessels due to advanced glycation end product 
formation or AGEs. Furthermore the generation of other tissues that are of clinically relevant 
size will be dependent on the formation of a functional vasculature, which begins with the 
stabilization of endothelial cell sprouts to form neovessels. The mechanisms of vascular 
stabilization began with the notion that pericytes, or mural cells could act directly on newly 
branched vessels to stabilize their sprouting and conditioning them into functional vessels. This 
paracrine signaling mechanism was initially proposed by D’ Amore13. 
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Figure II-3. Cell-cell interactions in forming vessels. EC recruit mesenchymal cells via 
elaboration of soluble factors such as platelet derived growth factor, heparin binding epidermal 
growth factor, or basic fibroblast growth factor. The mural cell precursors migrate to the EC 
where they make contact. The heterotypic interactions lead to the activation of transforming 
growth factor beta, which induces the mesenchymal cells to express SMC/pericyte markers and 
inhibits EC proliferation. Alterations in the microenvironment brought about by injury and or 
ischemia disrupt this balance leading to local increases in growth stimulators such as FGF and 
vascular endothelial cell growth factor. These changes result in the cell proliferation that 
characterizes normal wound healing and a variety of pathologies. Adapted from: Cardiovasc Res. 
1996 Oct;32(4):687-98. 
The problem with neovascularizatrion in engineered tissues is partially due to the lack of 
understanding over the exact distances and cell densities that enable this co-culture based 
stabilization effect. What is required is precise, reproducible patterning of these two cell types in 
a three dimensional, biologically relevant matrix material to study and observe this effect of 
mural cell migration and subsequent stabilization of endothelial cell neovessels. Furthermore, 
previous studies have shown multiple sources for potential mesenchymal stem cells, and it is still 
undetermined if all the sources have the capacity to exhibit this vascular stabilization phenotype.  
Present efforts have relied on microfluidic devices to study of these interactions
14-16
. The 
use of these linear fluidic setups, allows reproducible spatial control over the position of the two 
cell types in question, to allow image compatible, defined interactions to take place. These 
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studies generally allow the initial fluid flow of a gel prepolymer with cells to be injected on one 
end, and a cytokine gradient of interest, to be encapsulated through a gel on the other end. With 
pH based crosslinking for weak collagen gels, the system can then be stabilized to allow studies 
of cell growth and migration through the collagen material. Some limitations of this method are 
the reliance on the silicone elastomer, which provides the housing required for the fluidic device, 
which ultimately confound the biological studies, as well as the limited hydrogel types that have 
been used.  
 
Figure II-4 Proof-of-principle utility of the microfluidic cell migration platform with other 
cell types and in co-culture. Cells were fixed and stained for actin by Rhodamin-Phalloidin 
(yellow) and for nuclei with DAPI (blue). Concentration and pH at polymerization of collagen 
gel are indicated in the corner of scaffold region. 0.2% means collagen concentration of 2.0 
mg/ml. White dotted lines delineate the collagen gel scaffold while the small white rectangle 
marks a PDMS post (150 µm × 150 µm). (a) Co-culture of HMVEC and MTLn3 (seeded at 
1,000 cells /mm2). 4 days after HMVEC seeding and 5 days after MTLn3 seeding. Migration of 
HMVEC is faster on the condition side than the control side. (b) Co-culture of HMVEC and 
U87MG cells . 7 days after HMVEC seeding and 8 days after U87MG seeding. U87MG express 
GFP (green) which can be used to distinguish the cells from HMVEC. Note similar migration 
characteristics on the condition and control sides. (c) Co-culture of HMVEC and 10T 1/2. 4 days 
after HMVEC seeding and 5 days after 10T 1/2 seeding. HMVEC were stained for von 
Willebrand factor (green) to distinguish them from 10T 1/2. Note HMVEC migration only on the 
control side. Adapted from: Lab Chip. 2009 Jan 21;9(2):269-75. 
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Aim 3: Assembly of Complex Cell Microenvironments Using Geometrically Docked 
Hydrogel Shapes 
While the focus of Aim 2 is to study the interactions between endothelial cell and 
different types of mesenchymal stem cells, one aspect of the work that is missing is enhanced 
spatial control over the cellular microenvironment. To more faithfully recapitulate 
vasculogenesis, multiple geometries and a non-linear format could be used. The natural 
progression of a complexity would involve simple systems with more complex geometry to 
study the migratory behavior of mural cells. This migration putatively takes place due to 
morphogen signaling gradients. In 1952, Alan Turning providing a closed form solution to basic 
morphogenesis, using chemical chemical equilibria in leiu of knowledge of gene products and 
protein diffusion
17
. His paper founded a field of reaction-diffusion systems, which display 
remarkable complexity in geometric patterning through the simple use of a few morphogen 
gradients. The equations Turing developed come directly from the basic movement functions of 
concentration dependent diffusion and simple geometries. His initial result is shown below to 
provide context for the form of the equation Turing solved. These equations were further 
developed in the paper to provide accurate descriptions of seemingly non-linear patterning which 





Figure II-5 Schematic drawing showing the difference between the morphogen gradient 
model and Turing model. (A) A morphogen molecule produced at one end of an embryo forms 
a gradient by diffusion. Cells “know” their position from the concentration of the molecule. The 
gradient is totally dependent on the prepattern of the morphogen source (boundary condition). 
(B) Adding a second morphogen produces a relatively complex pattern; but with no interactions 
between the morphogens, the system is not self-regulating. (C) With addition of the interactions 
between the morphogens, the system becomes self-regulating and can form a variety of patterns 
independent of the prepattern. [Art work by S. Miyazawa] Adapted from: Science. 2010 Sep 
24;329(5999):1616-20 
These types of morphogen gradients can be manipulated and designed to mimic very 
seemingly complex spatial geometries with the simple use of only two species acting in three 
ways as shown in Fig II-5C
18
. However, this demonstrates the potentially complicated cellular 
microenvironment that can be formed with relatively few agents. To further explore if these 
morphogen gradients might be at play with mesenchymal stem cells and endothelial cells, further 
cell interactions were studied to find a set of cells which qualitatively formed structures similar 
to pericyte migration. The model proposed by D’Amore suggested a dual morphogen gradient 
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interaction, similar to the example shown in Fig. II-5B. This radial type pattern is a consequence 
of the two overlapping morphogen gradients, such as VEGF or PDGF secretion and cell 
migration. There are more recent theories to explain the branching morphogenesis and linear 





Figure II-6 Different modes of signalling that might operate during collective migration. 
(A) All cells detect an extracellular gradient of a guidance factor (green) and read a signal, 
become polarised (indicated by red and green colouring of cells) in response to this signal and 
move in the direction of the gradient. (B) Only leader cells sense a primary extracellular 
guidance cue, and then instruct other cells to follow them. This can be achieved either by 
localised secretion of a secondary guidance signal (green), which is then detected by follower 
cells and used to polarise their behaviour. Alternatively, this interaction could be mechanical, 
whereby the leader cells `pull' on follower cells, resulting in their polarisation and movement in 
the direction of the leader cell. Finally, it could be that that the cells sense local deformations of 
the ECM as a result of the remodelling activity of the preceding cells. These mechanical 
interactions are indicated by the blue arrows. Adapted from: J Cell Sci. 2009 Sep 15;122(Pt 
18):3215-23. 
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This schematic shows how a single gradient might signal to a set of cells to migrate in a 
manner independent of each other, responding only to the primary morphogen gradient, or how 
local disturbances due to the presence of other cells can modify the migration effect due to 
collective functions. These interactions may all be occurring when in the context of mural cell 
migration to stabilize the neovascular microenvironment.  
One of the major obstacles to studying these effects and complicated morphogen gradient 
patterns is the lack of techniques to study and fabricate these morphogen gradients over the 
cellular scale. As shown in the previous section, linear patterns do not fully recapitulate the 2D 
or 3D geometry and gradient formation that migrating mural cells might be exposed to in vivo
20
. 
Therefore microtechnological approaches to controlling the complexity of multiple signaling 
morphogens and cell types is required to study these effects.  
Previous work has shown some capacity for shape specific hydrogels to be assembled to 
form microenvironments with enhanced collective complexity (Fig II-7)
20
. However, these 
studies lacked high fidelity (~10% yield) and relied on the use of hydrophobic interactions using 
oils to aggregate and localize subunits, which may contaminate and confound the establishment 
of delicate gradients. Therefore to fully explore the complex architecture of morphogen gradients 
formed by endothelial cells and pericytes, more robust and biologically motivated systems need 
to be developed. 
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Figure II-7 Secondary cross-linking of the microgel assembles. (A) Dissociated microgel 
assemblies after replacing mineral oil with culture medium without secondary cross-linking. (B) 
Stabilized microgel assemblies in culture medium after secondary cross-linking. (C) Dissociated 
microgel assemblies after secondary cross-linking with removed residual prepolymer. (D–F) 
Diffusion of dyes through the hydrogel. (D) Free diffusion of rhodamine-dextran (Mr = 10 kDa) 
out of the hydrogel into PBS. (E) Two groups of microgels labeled with rhodamine-dextran or 
FITC-dextran (Mr = 2,000 kDa) were assembled, and the rhodamine-dextran diffused throughout 
the entire hydrogel assembly. (F) Microgel assemblies with FITC-dextran- or Nile red-stained 
microgels. (G–I) Microbead-containing and plain microgels were used to model microgels 
containing two types of cells by varying the initial mixing ratios of these two types of microgels 
(1:1, 2:1, and 4:1, respectively). (Scale bars, 200 μm.) Adapted from: Proc Natl Acad Sci U S A. 
2008 Jul 15;105(28):9522-7. 
 
Aim 4: Tubular Silk Scaffolds for Small Diameter Vascular Grafts 
Mesenchymal stem cell and endothelial cell interactions on a micro-scale can be utilized 
to form microvascular networks for transport to individual cells, but vessel disease seen in 
ischemic heart due to coronary heart disease is generally on the millimeter size scale. 
Furthermore, the gradient based migration of neovessels with pericytes fundamentally 
interrogates the paracrine interactions between cells in a “bottom up” approach. The primary role 
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of vessels, large or small is to permit fluid flow to enhance nutrient and waste transport, which is 
difficult to study alongside the paracrine gradient interactions. Therefore approaching the 
nutrient transport problem from a “top down” approach may permit solutions for providing fluid 
flow to the microscale while also enabling studies or techniques that directly address the clinical 
need for small diameter vascular grafts to treat coronary artery disease.  
Previous tissue engineering approaches to fabricate blood vessels has met with some 
success, where the use of biodegradable materials or rolled cellular sheets allowed formation of 
vascular conduits. Previous approaches normally use poly(glycolic acid) or poly(lactic acid) and 
are seeded with mesenchymal stem cells, smooth muscle cells and endothelial cells
21
. These 
techniques yield biologically responsive grafts with good cellular characteristics, but are limited 
by polymer degradation rates. Vessels have been formed from entirely cellular materials, but are 
generally much weaker and have limited capacity to withstand physiologic pressures. 
Recently, Wu et al. showed that the use of a highly elastic material, poly(glycerol 
sebacate) (PGS) has favorable degradation kinetics compared to older materials, while 
maintaining cellularity and supporting remodeling in vivo (Fig II-8)
22
. Their system consisted of 
a porous PGS tube within a polycaprolactone (PCL) sheath. This composite material had greater 
suture retention when compared to PGS alone, and had tensile strength similar to the rat aorta. 
When heparin coated, they were shown to have minimal platelet adhesion and fibrin deposition, 
which was important in preventing thrombus formation. The graft supported physiologic 
pressures, and over the course of 90 days remained patent and remodeled extensively, resulting 




Figure II-8 a) Schematic representation of direct implantation of the cell-free graft and the 
proposed remodeling process of the graft into a biological neoartery. (b) SEM images of 
composite grafts to show surface topology; scale bar, 100 μm. Inset: top view of the graft; scale 
bar, 500 μm. (c) Lumen of the PGS tube; scale bar, 100 μm. (d) The PCL fibrous sheath; scale 
bar, 20 μm. (e) SEM of heparin-soaked PGS after incubation in platelet-rich plasma to show 
platelet adhesion and fibrin deposition. Scale bar, 10 μm. (f) SEM of unheparinized PGS after 
incubation in platelet-rich plasma; scale bar, 10 μm. An adherent platelet is circled in e and f to 
highlight difference in platelet morphology. Arrow indicates fibrin in f. (g) Platelet adhesion on 
PGS presoaked in varying heparin concentrations, quantified by lactate dehydrogenase assay (n 
= 5). P < 0.0001 between all groups. Abs, absorbance. (h) Suture retention and elastic moduli of 
grafts. &, break force of 9-0 suture. P < 0.05: *, composite graft versus 9-0 suture; +, composite 
graft versus rat aorta; #, composite graft modulus (n = 8) versus that of PGS (grafts without the 
PCL sheath, n = 3). n = 5 for other groups. (i) Gross appearance of the graft during host 
remodeling to assess integration with host tissue. From left to right: day 0, day 14, day 90 and 
day 90 (top and bottom). Scale bars, 2 mm; all ruler ticks 1 mm. Nondegradable sutures (black) 
mark the graft location. (j) Mechanical properties of neoarteries. Left, the burst pressure of the 
neoartery (n = 3) and native aorta (n = 4). Middle, stress-strain curves of arteries and new grafts. 
'New grafts' represents unimplanted composite grafts. 'PGS core' represents new grafts without 
the PCL sheath. Right, compliance of arteries and new grafts. Standard errors for new grafts and 
the PGS core are very small and barely visible at the plotted scale. For j, n = 3 for neoarteries and 
n = 4 for native aortas, new grafts and PGS cores. Data represent mean ± s.d. for g,h and mean ± 
s.e.m. for j. Adapted from: Nat Med. 2012 Jul;18(7):1148-53. 
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The degradation time of the PGS-PCL composite scaffold was slow enough to prevent 
failure of the graft yet fast enough to permit cellular infiltration and remodeling. Over time, the 
graft supported a thick layer of smooth muscle cells with some elastin and collagen deposition. 
Animals survived the initial immune response, and by day 90, few macrophages persisted (Fig 
II-9). This work required the use of a sheath material to provide mechanical stability during the 
early remodeling phase immediate after the surgery. While the PGS component of the scaffold 
degraded over the course of 90 days, the PCL component remained somewhat undegraded. 
Therefore, alternative scaffolds of only one material type may provide a biodegradable matrix 
which allows for cellular remodeling while still retaining the mechanical strength to connect with 




Figure II-9 Smooth muscle cell infiltration and organization at 14 d. (a) Smooth muscle cell 
distribution (α-SMA, green) within the remodeled graft wall. The tissue was split longitudinally, 
half of which is shown. Native aorta is on the right; its border with the graft is indicated by the 
dashed line; scale bar, 500 µm. L, lumen. (b) Magnified view of the mid-graft shows distribution 
of both α-SMA–positive (green) and α-SMA–negative cells. Nuclei counterstained by DAPI 
(blue); scale bar, 250 µm. (c) Further magnification of the mid-graft to view the complicated 
smooth muscle cell distribution (α-SMA, green); scale bar, 50 µm. (d) Distribution of endothelial 
cells (vWF, red) and smooth muscle cells (α-SMA, green) in the graft wall. Immunofluorescent 
images merged with the bright-field image (darkened to not overwhelm the fluorescent images). 
Dark spots (*) in the bright-field image might be residual graft material. Scale bar, 100 µm. 
Adapted from: Nat Med. 2012 Jul;18(7):1148-53. 
 
Aim 5: Hierarchically Designed Blood Vessels 
As described in previous sections, the phenotypic maturation of nascent blood vessels 
requires mural cell recruitment for stabilization. However, fully functional vasculature has an 
additional requirement for function and that is fluid flow and perfusion, which is in some ways 
the primary role of the vascular network in vivo, to provide adequate transport to support the 
individual cells in the body. This is particularly problematic for cardiac tissues due to the 
increased metabolic demand, and thus stricter requirements for vascular function. In the past 
there has been a gap between these two tenants of vascular design, where fluid flow and 
perfusion are not always utilized with mural cell stabilization. Part of this obvious incruiety is the 
fact that the size scales for these processes is significantly different as mural cell stabilization 
occurs for individual capillaries and tissue engineered vessels are historically on the order of 
millimeters. What is required therefore is a hierarchical network of branches, like the branching 
networks in vivo, to bridge these two size scale domains and combine these critical requirements 
of vascular function to establish transformative tissue engineered vasculature. 
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Figure II-10. Wall composition of nascent versus mature vessels.(a) Nascent vessels consist of a 
tube of ECs. These mature into the specialized structures of capillaries, arteries and veins. (b) 
Capillaries, the most abundant vessels in our body, consist of ECs surrounded by basement 
membrane and a sparse layer of pericytes embedded within the EC basement membrane. 
Because of their wall structure and large surface-area-to-volume ratio, these vessels form the 
main site of exchange of nutrients between blood and tissue. Depending upon the organ or tissue, 
the capillary endothelial layer is continuous (as in muscle), fenestrated (as in kidney or endocrine 
glands) or discontinuous (as in liver sinusoids). The endothelia of the blood-brain barrier or 
blood-retina barrier are further specialized to include tight junctions, and are thus impermeable to 
various molecules. (c) Arterioles and venules have an increased coverage of mural cells 
compared with capillaries. Precapillary arterioles are completely invested with vascular SMCs 
that form their own basement membrane and are circumferentially arranged, closely packed and 
tightly associated with the endothelium. Extravasation of macromolecules and cells from the 
blood stream typically occurs from postcapillary venules. Adapted from: Nat Med. 2003 
Jun;9(6):685-93. 
As shown diagrammatically in Fig. II-10, capillaries are distinguished from endothelial 




mural cells are required for vessel stabilization and function. Further development into larger 
vessels recruits / causes the differentiation of even more supporting and surrounding cells with 
smooth muscle cell proliferation and external eleastic lamina increasing the mechanical and 
elastic properties of the vessel. This effect is less pronounced for venules, but clearly 
multicellular interactions define the identity and profile of functional vessels.  
Present progress in addressing the gap between paracrine cell signaling to establish stable 
capillaries and larger vessel formation to support fluid flow has utilized microfluidics, or the 
microtechnology involved with fluid transfer on the micron level
24
. These technologies have 
shown that silicone elastomers can be designed to have branching channels that accommodate 
vascular-like fluid flow.  
 
 
Figure II-11 Pressure drop from radial inlet to central outlet of vascular network. The 
pressure drop is uniform across the network; due to venous scaling, more pressure drop occurs in 
the inlet generations than the outlet generations (A). Isometric view of the shear stress of the 
vascular network. Shear stress variation was minimized by utilizing both Murray's law for 
channel diameter relationships and channels with 1:1 aspect ratio (B). Adapted from: Tissue Eng 
Part A. 2010 May;16(5):1469-77. 
This work provides the underlying basis for fabrication of an engineered device with 
fluid flow networks on the capillary level. One major drawback of this technology however is its 
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reliance on the silicone elastomer, poly (dimethylsiloxane) for fabrication. While PDMS is a 
highly biocompatible material that allows exceptional oxygen exchange, it has very limited 
ability to transfer solutes and does not degrade in vivo. These properties exclude it as a potential 
material to form fully functional vascular networks, though it remains critical in development of 




Aim 1: Individual Cell Function : Electrical Conditioning of Human 
Embryonic Derived Cardiomyocytes 
ABSTRACT 
Rationale 
Differentiated human cardiomyocytes, from either embryonic or induced pluripotent stem 
cells have great potential to ameliorate heart disease through the therapeutic engraftment into the 
diseased heart. A current obstacle is the potential electrical mismatch between the host and 
therapeutic cells. Electrical field stimulation has shown to improve electrical and contractile 
properties in rat cardiomyocytes, but its effect on conditioning human embryonic stem cell 
derived cardiomyocytes has not been explored.  
Objective 
To study the effect of electrical field stimulation on human embryonic stem cell derived 
cardiomyocyte function. 
Methods and Results 
We report the use of electrical field stimulation to condition human embryonic derived 
cardiomyocytes. This biomimetic cue was harnessed to modulate the autonomous beating 
frequency of the cardiomyocytes over a physiologic range. Furthermore, the stimulation 
improved contractile protein assembly, myofibrillar ultrastructure and modified global gene 
expression in a dose dependent manner. A biological cause for the beating frequency changes 
was discovered; the voltage gated inward rectifier potassium channel, encoded by KCNH2, was 
shown to have a causal relationship with increased autonomous beating frequency, demonstrated 
through blockade with the channel inhibitor E-4031.  
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Conclusions 
These results show the conditioning effect of electrical field stimulation on human 
embryonic stem cell derived cardiomyocytes, enhancing contractile protein assembly and 
enabling control of autonomous beating frequency through KCNH2 function. 
 
INTRODUCTION 
A human cardiomyocyte (CM) source, either human embryonic stem cells (hESC) or 
induced pluripotent stem cells (iPSC), has the potential to revolutionize heart disease treatment 
by directly repairing heart function with new cardiomyocytes
5, 9, 25-28
. Though promising, cell and 




 The myogenic potential of hESCs or iPSCs enables direct enhancement of 
contractile function, though to do so necessitates coordinated electrical depolarization of the 
therapeutic cells
7, 32-37
. Therefore, a critical feature of any cell-based therapy will also include 
electrical integration with native heart tissue, since mismatch could induce arrhythmia, further 
exacerbating clinical prognosis8. Furthermore, the injured myocardium may be an additionally 
challenging environment, as fibroblast proliferation may reduce possible electrical conductivity 
and adjacent signaling
38
. Therefore, due to potentially limited environmental cues, control over 
intrinsic beating rates of implanted cells will be especially critical
39, 40
. Furthermore, to fabricate 
potential tissue based therapies with significant force generation, the individual constituent cells 
will be required to beat synchronously
10, 41, 42
, further emphasizing the need for electrical control. 
Recent studies have shown promising effects of cell therapies, although methods to control 
autonomous electrical behavior of differentiated human cardiomyocytes are limited
12, 36
. 
 Cardiac cells and tissues distinctively exemplify electromechanical coupling with 
electrical signals influencing force generation and contractile timing. Electrical field stimulation 




. This stimulus was shown to enhance cardiac function in neonatal rat 
cardiomyocyte based tissues
43
. Through these electrical signals, the functional assembly of the 
cardiac contractile apparatus was improved, increasing force generation and electrical reactivity. 
Therefore, electrical stimulation might provide the required control to overcome some the 
obstacles in electrical integration. We therefore hypothesized that a biomimetic electrical signal 




hESC-CMs were maintained in hESC-CM Media which contained StemPro-34 with 
nutrient supplement (Life Technologies), 1% L-glutamine (Sigma), 150 µg/mL transferrin 
(Roche Applied Science), 50 µg/mL L-ascorbic acid (Sigma), 10 ng/mL VEGF(PeproTech), 5 
ng/mL bFGF (PeproTech), and 1% penicillin/streptomycin (Sigma). EBs were cultured in 37oC 
and 5% CO2 and media was changed every other day. 
 
Fabrication of Microbioreactor 
Microbioreactors were fabricated as previously described. Briefly, the bioreactor was 
molded with PDMS (Dow Corning) around a negative custom design fabricated by QuickParts. 
The PDMS bioreactor had 4x4 wells of 5 mm x 5 mm. Carbon rods of 1.3 mm in diameter 
spanned the two ends of the bioreactor such that four wells horizontally arranged received the 
same stimulation. The PDMS bioreactor was sealed to a 75 x 25 mm glass slide (Fisher) using 
plasma treatment (PDC-002, Harrick Plasma).  
Microbioreactors were loaded with approximately 10 differentiated EBs per well in 
hESC-CM media and cultured for three days prior to electrical stimulation. Leads from an S88X 
Dual Output Square Pulse Stimulator (Grass Technologies) were connected to the carbon rods 
with standard alligator clips and cells were stimulated continuously for seven days. Cells were 
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pulsed with a square wave at 5V/cm for 2 ms at three frequencies: 0.5 Hz, 1 Hz, and 2 Hz. The 
control group was also cultured in the bioreactor but did not receive any stimulation. 
 
Video Acquisition 
EBs were equilibrated in fresh hESC-CM Media for 1 hour. Videos of EBs were taken 
using the Olympus IX81 inverted microscope on a heated glass plate (Bioscience Tools) set to 
37oC. Phase contrast videos of each EB were acquired using the Hamamatsu C4742-95 at 15 
frames per second or with the AmScope MU500 at 30 frames per second. During acquisition, 
EBs beat freely without the addition of any external field stimulus. 
 
Area Change Measurement/Frequency Measurement 
Acquired videos were analyzed for area change and frequency using a custom-made 
MATLAB-based GUI. Images were thresholded on a sliding scale defined by the user, to 
separate the darker EB from the lighter surrounding. This thresholding condition was applied to 
all frames within the video, and the area of the EB was measured for each time point. The data 
were normalized to the maximum area calculated so a fractional area change was determined for 
each frame. Resulting graphs demonstrated peaks of maximum contraction, which were counted 
to determine frequency of contraction. 
 
Strain Analysis 
Videos were further analyzed for strain generation using MATLAB and PIVlab (v 1.3.2), 
a freely available particle tracking tool built for MATLAB. Videos were first separated into 
individual frames and saved as a sequence of images, which were subsequently loaded into 
PIVlab. The analysis window was then masked to include only the EB of interest. As EBs beat, 
gray intensity patterns translated and were detected by the built in cross-correlation function. In 
short, this function compared interrogation areas between two frames, and generated velocity 
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vectors between two areas of similar intensity pattern in adjacent frames. Interrogation areas 
were made sufficiently small and were computed in three sequential passes (64 pixels, 32 pixels, 
and 16 pixels) to obtain accurate correlations. Velocity magnitudes that measured greater than 7 
standard deviations from the average velocity were excluded from the data and replaced by 
linearly interpolated data. 
To generate heat maps of velocity magnitude, data were set to the same colormap limits 
(0-28 µm/s). Strain rate was also determined using built-in PIVlab functions, and compared the 
point to point contraction or relaxation. An area integral of strain rate was determined for each 
frame and averaged over the entire EB area, resulting in a strain rate which could be traced over 
time. Positive strain rates, referring to contractile events were subsequently summed to result in 
the cumulative strain generated by the EB over a six second video. Dividing by the number of 




hESC-CMs were harvested after seven days of electrical stimulation and dehydrated in 
20% sucrose (Sigma) overnight. Samples were cryosectioned at 8 µm. Sections were thawed and 
rehydrated in PBS for 5 minutes and blocked with 10% horse serum (Sigma) in PBS for 20 
minutes. Slides were stained with primary antibodies for one hour using: mouse anti-Troponin I 
(4 µg/mL, Developmental Studies Hybridoma Bank), mouse anti-Titin (4 µg/mL, Developmental 
Studies Hybridoma Bank), or rabbit anti-hKV11.1, hERG (1:400 dilution, Alomone Labs). After 
3 washes with PBS, slides were stained for one hour with the following secondary antibodies: 
Oregon Green® 488 Goat Anti-Mouse IgG (2 µg/mL, Life Technologies) for Troponin-T and 
Titin, and Texas Red® Goat Anti-Rabbit IgG (2 µg/mL, Life Technologies) for hERG. All slides 
were counterstained for 5 minutes with DAPI (300 nM, Life Technologies). Slides were 
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visualized using the Olympus IX81 inverted microscope and fluorescence images were taken 
with the Hamamatsu C4742-95. 
 
Transmission Electron Microscopy 
Samples were fixed in 2.5% glutaraldehyde in 0.1 M Sorenson’s buffer and processed for 
TEM. Samples were examined under the JEOL JEM-1200 EXII electron microscope and images 
were acquired with the ORCA-HR digital camera (Hamamatsu). 
 
Quantitative PCR 
RNA from embryoid bodies was extracted with TRIzol reagent (Life Technologies) after 
7 days of stimulation and was quantified for yield and purity using NanoDrop (Thermo 
Scientific). Reverse transcription was performed using Ready-To-Go You-Prime First-Strand 
Beads (GE Healthcare Life Sciences) as per manufacturer protocol. Briefly, 2 µg RNA were 
resuspended in 30 µL DEPC H2O (Life Technologies) with 0.3 µL of 0.2 µg/µL Random 
Primers (Life Tehcnologies) and placed in a tube with the First-strand reaction mix. The mix was 
placed in a 37
o
 water bath for one hour. Quantitative real-time PCR was performed on the 
StepOnePlus Real-Time PCR System (Applied Biosystems) where each well contained a 
reaction mix totaling 15 µL, with 5 µL of 1:10 diluted cDNA, 7.5 µL SYBR Green PCR Master 
Mix (Applied Biosystems), and 0.2 µM primers. The primers used are listed in Table V-1. The 
integrity of each primer was checked by ensuring a single product with each melting curve. The 
data were analyzed using the ΔΔCt method, where samples were normalized to the calsequestrin 






 Forward Reverse 
GAPDH GGAGCGAGATCCCTCCAAAAT GGCTGTTGTCATACTTCTCATGG 
CASQ2 GGCAGAAGAGGGGCTTAATTT GAAGACACCGGCTCATGGTAG 
TNNI3 TTTGACCTTCGAGGCAAGTTT TGCAGAGATCCTCACTCTCCG 
GJA1 GGGACAGCGGTTGAGTCAG TGTTACAACGAAAGGCAGACTG 
TTN CCCCATCGCCCATAAGACAC CCACGTAGCCCTCTTGCTTC 
Nkx2.5 CCTCAACAGCTCCCTGACTC CTCATTGCACGCTGCATAAT 
NPPA CAACGCAGACCTGATGGATTT AGCCCCCGCTTCTTCATTC 
MYL2 TTGGGCGAGTGAACGTGAAAA CCGAACGTAATCAGCCTTCAG 
RYR2 ACAACAGAAGCTATGCTTGGC GAGGAGTGTTCGATGACCACC 
SLC8A1 ACAACATGCGGCGATTAAGTC GCTCTAGCAATTTTGTCCCCA 
ANKRD1 CGTGGAGGAAACCTGGATGTT TCTCGGGCGCTAATTTTTGCT 
MYH6 GCCCTTTGACATTCGCACTG CGGGACAAAATCTTGGCTTTGA 
IGF1R AAAATGCTGACCTCTGTTACCTC GGCTTATTCCCCACAATGTAGTT 
CACNA1 AATCGCCTATGGACTCCTCTT GCGCCTTCACATCAAATCCG 
KCNH2 CAACCTGGGCGACCAGATAG GGTGTTGGGAGAGACGTTGC 
Table III-1. Primers Used for qPCR 
 
Microarray 
EBs after 7 days of stimulation were isolated from the bioreactors, flash frozen, and sent 
to Expression Analysis (Durham, NC) for RNA isolation and whole genome expression profiling 
and analysis. The Illumina HumanHT-12 v4 Beat Chips were used to generate the expression 
profile for 3 samples of each of the three stimulation groups and control. Each of the stimulation 
groups were compared to control using a permutation analysis for differential expression 
(PADE) and tested for statistical significance. 
Genes with frequency dependent upregulation or downregulation of on average at least 
two fold were determined for all transcripts identified by the PADE analysis. Further 
identification of specific cardiac genes was done manually. Heat maps were generated using 
GenePattern (Broad Institute)
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Beating frequency of EB derived cardiomyocytes were derived using the same video 
acquisition and analysis as above. For the physiologic drug study, baseline videos were first 
acquired. Fresh hESC-CM media containing isoprenaline (Sigma) at a final concentration of 1 
µM was added to all groups, which were allowed to equilibrate for 10 minutes before videos of 
the same EBs were acquired. For the drug inhibition study, after baseline videos were acquired, 
E-4031 (Tocris) was added to all groups at a final concentration of 5 µM in fresh hESC-CM 
media and allowed to equilibrate for 20 minutes before taking additional videos. EBs were 
washed with hESC-CM media three times, allowed to equilibrate for 20 minutes, and videos of 




Video entrainment data were presented as average values ±SEM and statistically 
analyzed using two-way ANOVA comparing between experimental groups and time points 
(n≥30, p<0.05). Contractile video analysis was presented as average strain ±SEM and analyzed 
using one-way ANOVA comparing experimental groups (n=3, p<0.05). PCR results were 
presented as fold change relative to control ±SEM and analyzed using one-way ANOVA (n≥3, 
p<0.05). Effects of beating frequency are presented as averages ±SEM and was tested using two-
way ANOVA comparing between experimental groups and presence of drug (n=3, p<0.05) 
 
RESULTS 
PDMS Microbioreactor for Electrical Stimulation 
We present the use of a multiwell microbioreactor system for the interrogation of 
electrical stimulation paradigms on conditioning human embryonic stem cell derived 
cardiomyocytes. The basic design of the bioreactor follows the spacing and format of a 96 well 
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plate, while providing the capacity to test four independent electrical stimulation regimes, with 
quadruplicate wells for biological replicates. This microbioreactor system has specific features 
that aided electrical screening of hESC CMs, it is rapid to assemble, and does not require the use 
of specialized equipment, it is composed of inexpensive components which made  the reactors 
disposable, it is autoclavable ensuring long term sterility, and it is imaging compatible with a 
glass slide base, permitting real-time video acquisition. hESCs were differentiated into beating 
CMs using previously established protocols. This resulted in beating embryoid bodies (EB) 
which were placed into the bioreactor wells. They were allowed to attach to the underlying glass 
substrate for three days, and were exposed to four different stimulation paradigms with daily 
media changes. 
 
Electrical Stimulation Frequency Conditions Autonomous Beating Rates 
To characterize the effect of electrical stimulation on the function of hESC CMs, an 
unstimulated control along with three experimental electrical stimulation frequencies, 0.5, 1 and 
2 Hz, were chosen to simulate bradycardia, eucardia and tachycardia, corresponding to heartrates 
of 30, 60 and 120 beats per minute (Fig III-1). The cells were exposed to a linear voltage 
potential of 5 V/cm, consistent with the voltages used in previous experiments involving the use 
of neotnatal rat cardiomyocytes. Over the seven-day course of stimulation, video was acquired at 
three time points, day one, three and seven. It is important to note that during video acquisition 
the cells were not externally paced with an electric field, and the beating frequencies reflect 
intrinsic changes in the autonomous beating rate of the hESC CMs. The videos of beating CM 
EBs were quantified using a MATLAB script written in our laboratory, which quantifies the area 
change associated with each frame during EB contraction and is expressed as a fraction 
compared to the most relaxed state. For unstimulated control hESC-CM EBs, their contraction 
was periodic, but out of phase with one another, consistent with the observation that hESC CM 
normally display some heterogeneity in beating frequency when kept in standard culture.  
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However, with electrical stimulation, the EBs showed increased synchronization with faster 
stimulation frequencies. More than increased synchronization, the frequency of EB contraction 
was altered by exposure to the electrical field stimulus, with qualitative increases in the 1 and 2 
Hz stimulated groups in comparison to control (Fig III-2A). 
 
Figure III-1. Schematic of microbioreactor setup. Differentiated hESC derived 
cardiomyocytes in the form of embryoid bodies were placed into a PDMS bioreactor with 16 
wells in a 4x4 format. Carbon rods were placed parallel to the EBs such that there were four 
replicates of four experimental groups. The four experimental groups consisted of a control with 
no stimulation and three stimulation groups of 0.5 Hz, 1 Hz, and 2 Hz. 
Quantification of this increased beating frequency for multiple EBs (n= 30) was 
aggregated by calculating the average beating frequency of the EBs in the various experimental 
conditions. By the seventh day of stimulation, the 2 Hz stimulated group had a significantly 
higher autonomous beating rate, beating nearly two-fold faster than the 0.5 Hz stimulated group 
and approximately 30 BPM faster than the unstimulated control.  Both the 1 Hz stimulated group 
and the unstimulated control group had average beating frequencies of ~1 Hz, however, the 0.5 
Hz group had a lower average beating rate than any of the other groups. Despite this, the 0.5 Hz 
group still exhibited the physiologic property of overdrive suppression, the EB’s beating 
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frequency could not be forcibly brought down completely to 0.5 Hz, the presence of individual 
cells within the EB beating above 0.5 Hz maintained a higher beating rate for the entire EB cell 
community (Fig III-2B). What is striking is that even with electrical field exposure, the 0.5 Hz 
stimulation group had a lowered beating frequency compared to unstimulated control, 
demonstrating that the presence of a depolarizing electric field alone was not enough to modify 
beating frequency, the added stimulation did not by itself increase the intrinsic beating rate above 
the unstimulated amount. Therefore, electrical stimulation frequency was the primary 
determinant affecting the intrinsic state of the CMs. This is the first demonstration that hESC 
CMs can be controlled with autonomously variable beating frequencies. 
 
Cumulative Strain in Conditions hESC-CMs 
To understand the contractile effects of stimulation on EB function, 2D strain analysis 
was performed based on a previously defined method
52
. A MATLAB-based software, where a 
frame-by-frame cross correlation function detected movement of points within the entire area of 
the EB, yielded velocity maps of cell movement within a contracting EB (Fig III-2C). EBs had 
similar dynamic ranges for speed suggesting that the increased beating frequency did not grossly 
alter the basic profile of contraction. Contraction for all groups was a coordinated event, with 
movement of points inward towards a central location within the EB. Local areas of high 
velocity in the heat maps showed spatial heterogeneity of contraction, suggesting local densities 




Figure III-2. Frequency entrainment and strain analysis of autonomously beating hESC-
CMs. A. Fractional area change of the four experimental groups as a function of time. B. 
Frequency of autonomously beating EBs ±SEM as a function of days of stimulation for the 
different stimulation conditions (n=30, p<0.05) C. Sample velocity maps of EBs during 
contraction. Red colors and longer arrows represent higher velocities whereas blue colors and 
shorter arrows represent lower velocities. Scale bar = 50 µm D. Representative overall strain of 
an EB over time. Positive strains refer to contraction while negative strains refer to relaxation. E. 
Strain rate per beat and cumulative contraction strain ±SEM over the course of a 6 second video 
for control unstimulated, 0.5 Hz stimulated, 1 Hz stimulated, and 2 Hz stimulated groups (n=3, 
p<0.05). 
While the individual heat maps provided spatial information on individual beats, these 
velocity maps were compared over time to assess temporal dynamics of beating. Comparing the 
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relationships between velocities at all points within the EB yielded a strain rate (Fig III-2D). 
These strain rate traces show when the cell is contracting (positive strain) and relaxing (negative 
strain). Frequencies of contraction were significantly higher in the 2 Hz group, an effect of 
stimulation consistent with previous experiments. Beats in 1 Hz and 2 Hz stimulated groups had 
consistent peak strain rates, suggesting electrical stimulation enhanced their coordination, both in 
frequency and in movement. The 0.5 Hz group, which was described earlier to have a limited 
ability to be paced due to overdrive suppression, consistently displayed a less coordinated 
beating pattern than the 1 Hz and 2 Hz stimulated group. 
From the traces, a total strain of contraction could be calculated, with EBs displaying 
strains in the physiologic range, ~10-20% (Fig III-2E). Per beat, the 2 Hz stimulated group 
contracted with the highest average strain, significantly different from the unstimulated group 
(p<0.05). Therefore the presence alone of the electric field had an effect on the strain formed per 
beat in the hESC CMs, unlike the effect of electrical stimulation on beating frequency, where the 
specific rates of stimulation caused functional changes. Cumulative contractile strain over 6 
seconds showed the 2 Hz group generated more than twice the total amount of strain than the 
control or 0.5 Hz groups (Fig III-2F). Perhaps most interestingly, the overall effect of electrical 
stimulation on contractile function was additive through two means, (1) the strain generated per 
contraction was enhanced through stimulation, and (2) intrinsic beating frequency was altered 
specifically by the frequency of the stimulus. These two effects of electric field stimulation 
summed to cause greater than a 2 fold increase in cumulative contractile strain. 
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Figure III-3. Troponin organization of stimulated hESC-CMs. Immunostains of control 
unstimulated (A), 0.5 Hz stimulated (B), 1 Hz stimulated (C), and 2 Hz stimulated (D) hESC-
CMs demonstrating increasing levels of troponin (green) staining and organization. Slides were 
counterstained with DAPI. Scale bar = 50 µm 
 
Troponin Organization 
To examine the protein level changes induced by exposure to electrical stimulation, 
immunofluorescent staining for cardiac troponin I was performed on hESC CM EB’s (Fig III-
3A-V-3D). There was a high amount of troponin I in all the groups, with mild increase 
associated with increased stimulation frequency.  However, there was a clear increase in troponin 
organization dependent on stimulation frequency. The sarcomere organization in the control 
group was diffuse with only a few local regions of contractile fiber organization. Sarcomeres 
with striations were visible in the 0.5 Hz stimulated group, but the 1 Hz stimulated group had 
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pronounced contractile fibers with multiple sarcomeres visible, forming a banded, striated 
appearance within the cell. The 2 Hz stimulated group had all of these features, but additionally 
had longer and thicker fiber organization. The cells also had increased alignment to one another, 
with contractile fibers running in parallel across multiple cells, demonstrating an even higher 
amount of protein organization, transcending the individual cell, forming a multicellular 
contractile group. Therefore, electrical stimulation was a strong cue for organizing the contractile 
proteins present in hESC derived CMs, with a strong effect on sarcomere organization. 
 
Cardiac Ultrastructure 
Transmission electron microscopy (TEM) revealed a similar trend for cardiac protein 
organization with increasing electrical stimulation (Fig III-4). Most of the common TEM 
features for cardiac cells were visible on all of the groups, including tight junctions, 
mitochondria and contractile fibers. Each of the groups showed myofibril organization on the 
cytosolic, exterior aspect of the cell, close to the cell membrane, though these myofibrils in the 
unstimulated cells were generally disorganized, running in multiple directions and only 
intermittently associated with Z lines. It was rare to observe more than three sarcomere subunits 
repeat in a single myofibril and the fibers themselves were not aligned to each other. For the 
groups exposed to electrical stimulation, there was an organizational effect on assembly of the 
contractile apparatus. Sarcomeres often created relatively long myofibrils with more than five 
repeating sarcomere subunits and had increased organization of thick filaments which were 
associated with Z disks.  Both the 0.5 and 1 Hz stimulated groups had thickened myofibrils 
spanning through cell membranes, demonstrating contractile force generation across multiple 
cells. The 2 Hz stimulated group had exceptionally thick sarcomere formation, with long, 
continuous repeats of sarcomere subunits with Z disks that were much more distinct than any of 
the other groups. Each sarcomere was nearly twice as thick as those found in the 0.5 and 1 Hz 
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groups, and they showed strong alignment even between cells. Overall, there was a dose 
dependent effect of electrical stimulation frequency on cardiac ultrastructure 
 
 
Figure III-4. Ultrastructural organization of stimulated hESC-CMs. Transmission electron 
microscopy of control unstimulated (A,E), 0.5 Hz stimulated (B,F), 1 Hz stimulated (C,G), and 2 
Hz stimulated (D,H) at 20,000x (A-D) scale bar = 1um and 50,000x (E-H) scale bar = 500nm 
magnifications. Z-bands and corresponding myofibrils are clearly seen in all groups, and become 
thicker and more organized with frequency of stimulation. Other aspects of cardiac tissue such as 
numerous mitochondria and adherens junctions were also seen. 
 
Cardiac Gene Expression 
While electrical stimulation caused increased organization of contractile proteins, qPCR 
was conducted to assess if protein expression levels were also altered (Fig III-5). Structural 
protein expression changed as a function of electrical stimulation with troponin, connexin 43 and 
titin all dose dependently upregulated with increasing stimulation frequency. Troponin and 
connexin 43 are associated with increased maturity and function of cardiomyocytes, and titin is a 
well-known protein involved in sarcomeric organization, therefore this increase in expression of 
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these contractile structure proteins is consistent with the fluorescent and TEM results. So, 
beyond organizing the structural cardiac proteins in hESC CMs, electrical stimulation also 
increased their expression.  
 
 
Figure III-5. qPCR of cardiac markers. Quantitative PCR of cardiac markers for the different 
experimental groups. Results are normalized to calsequestrin expression and displayed as a fold 
change relative to control ±SEM. *denotes statistically significant differences between groups 
where connected lines denote multiple groups as independently different from the 2 Hz group 
(n=3, p<0.05). 
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To follow changes in cardiac markers not directly structural, but have been shown to 
influence downstream cardiac maturation, differentiation markers nkx2.5, atrial naturetic 
peptide(NPPA), Cardiac Ankyrin Repeat Protein (ANKRD1), and Myosin Light Chain 2v 
(MYL2) were assessed for the different stimulation regimes. Nkx2.5, NPPA and ANKRD1 
expression were significantly upregulated with electrical stimulation, suggesting that electrical 
stimulation contributes to further cardiac specification in hESC CMs. Myosin Light Chain 2V, a 
marker of ventricular cardiomyocytes, was upregulated more than 2 fold, further demonstrating 
that electrical stimulation may change the differentiation and specification of hESC CMs.   
A critical feature of cardiac function is electro-mechanical coupling. qPCR revealed 
significant differences in two genes implicated in the ion handling of contraction, RYR2 and 
SLC8A1. RYR2 or ryanodine was increased nearly threefold in the 2 Hz stimulated group, 
associated with the change to a more mature, intracellular, sarcoplasmic reticulum source of Ca
2+
 
for contraction.  Corresponding to the internal calcium handling change, SLC8A1, encoding for 




 exchanger , was significantly increased in the 2 Hz group. An 
antiporter membrane protein, it is responsible for removal of intracellular calcium, and is 
associated with cardiac cell relaxation. Upregulation of such a gene would allow increased 
relaxation in response to a rapid beating frequency induced by a higher electrical stimulation 
frequency.  These results indicate that electrical stimulation modified gene expression of relevant 
cardiac proteins in a frequency dependent manner. 
 
Microarray Expression Profiles 
Though the expression of many standard cardiac genes was upregulated, due to the 
relatively unknown effects of electrical stimulation, we performed whole genome expression 
profiling to attempt to gain a more global understanding of the effect of electrical field 
stimulation on hESC CMs.  Surprisingly, a large number (249) of genes were dose dependently 
changed by electrical stimulation. In all, 106 genes demonstrated a frequency dependent 
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upregulation of more than two fold change and 143 genes demonstrated a frequency dependent 
downregulation of more than two fold change (Fig III-6A). With only one week exposure to 
electrical stimulation, broad expression changes were seen in a dose dependent manner across 
the groups. However to continue exploring some of these potential changes, a subset of genes 
directly salient to cardiac differentiation and function were more closely examined. Markers of 
non-muscle differentiation, including NEUROD1 for neurogenic differentiation, and CDH5, 
VWF and NOTCH2 for vascular differentiation were significantly downregulated by stimulation. 
Furthermore, non-cardiac muscle markers, such as CNN2 and MYLK for smooth muscle and 
MYOD1 for skeletal muscle were also downregulated. This suggests that electrical stimulation 
caused an enhancement of cardiac cells relative to other lineages. 
In regards to other cardiac specific markers, many were differentially expressed with 
stimulation. Specifically, ISL1, a marker for second heart field was upregulated, while SLN, a 
marker for atrial myocytes was downregulated. These changes together with the MLC2V PCR 
result, further suggests specification towards a more ventricular type cardiac population. 
Stimulation also upregulated genes involved in cardiac hypertrophy (IGF1R), calcium handling 
(CAMK2B), and connectivity (GJA5).  
Ion channels important in the cardiac action potential were significantly upregulated with 
electrical stimulation, including a channel for pacemaker current (HCN2), a voltage gated 
sodium channel (SCN1B), and several potassium channels (KCNH2, KCNF2, KCND2). These 
changes are important since exposure to an electrical field might modify numerous proteins 
directly responsible for the native action of depolarization. It was clear, therefore, that electrical 
stimulation caused a wide range of expression changes consistent with cardiac development on 
cell specification, structural, and electrical levels. However, there was one gene found which had 
the highest relative fold change in the subset of genes we examined, KCNH2, the human ether-a-
go-go related gene (hERG), which functions by forming the voltage gated inward rectifying 
potassium current allowing rapid repolarization of a cardiomyocyte. 
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Figure III-6. Gene expression microarray of stimulated hESC-CMs. A. Genome wide profile 
of all genes dose-dependently upregulated or downregulated with stimulation. 106 genes were 
upregulated in a frequency-dependent manner on average of at least 2-fold and 143 genes were 
downregulated in a frequency-dependent manner on average of at least 2-fold. B. A subset of 
salient genes upregulated or downregulated with stimulation. 
 
hERG Channel Function Mediates Electrical Conditioning of hESC-CMs 
The identification of differential KCNH2 expression from the microarray, suggests a 
specific means through which hESC CMs respond to electrical conditioning. Visualization of the 
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protein, hERG, was accomplished by immunofluorescent staining, which showed increased 
expression in the higher frequency stimulated groups (Fig III-7A – IV-7D). The 1 Hz group 
qualitatively shows an increase in the number of cells that strongly express hERG, but the 2 Hz 
group had a large region of cells that highly expressed KCNH2 along with troponin. To further 
validate the microarray results, qPCR for KCNH2 quantitatively assessed the expression levels 
between groups (Fig III-7E). KCNH2 expression indeed was dependent on frequency of electric 
field, and the 2 Hz group had over two fold change in KCNH2, significant compared to any other 
group. 
To determine if there was a causal effect of increased KCNH2 expression on the intrinsic 
beating rate of the cardiomyocytes due to electrical stimulation, the drug E-4031, a reversible, 
but highly specific blocker of the KCNH2 channel, was used on the stimulated cardiomyocytes 
at day seven of stimulation (Fig III-7F). Initially, the beating EBs had different autonomous 
beating rates, but the addition of E-4031 reduced the average beating rate differentially, 
consistent with the relative expression of the KCNH2 channel. The greatest effect was shown in 
the 2 Hz group which showed a 57% decrease in the average beating frequency, while the 1 and 
0.5 Hz beating frequencies were decreased 16 and 3 % respectively. Interestingly, the 
unstimulated group showed a 27% decrease. These reductions in intrinsic beating frequencies 
correlate to the relative gene expression from the PCR where the increased expression of 
KCNH2 in the 2 Hz group left the CMs more sensitive to E-4031 blockade. However, this 
KCNH2 specific effect was rescued with subsequent removal of the blocker, and the 
cardiomyocytes were able to regain their original beating frequencies entirely, showing a causal 
relation of KCNH2 function with average autonomous beating rate. 
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Figure III-7. KCNH2 overexpression mediated frequency entrainment. Immunostain of 
troponin (green) and KCNH2 (red) of (A) Control unstimulated, (B) 0.5 Hz stimulated, (C) 1 Hz 
stimulated, and (D) 2 Hz stimulated groups. Groups show frequency dependent increase in 
positive staining for KCNH2. Scale bar = 50 µm. E. qPCR of KCNH2 confirms the upregulation 
with stimulation. Shown as average fold change ± SEM. *denotes statistically significant 
differences between the 2 Hz group and the 1 Hz, 0.5 Hz, and control groups (n=3, p<0.05). F. 
The differential beating frequency of EBs as shown in baseline was abolished with the addition 
of the specific KCNH2 inhibitor E-4031 and was regained after washing out the drug. * denotes 
statistically significant differences between the 2 Hz group and the 1 Hz, 0.5 Hz, and control 
groups (n=8, p<0.05). NS denotes no statistical difference between control, 0.5 Hz, 1 Hz, and 2 
Hz groups when exposed to E-4031 (n=8, p<0.05). ** represents a statistically significant 
difference for 2 Hz between baseline and when exposed to drug, and also a statistically 
significant difference for 2 Hz between exposure to drug and washout (n=8, p<0.05). 
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DISCUSSION 
This present study shows for the first time, to our knowledge, the effect of electrical 
stimulation on hESC derived cardiomyocytes, which fundamentally increased their functional 
assembly and programmed their intrinsic beating frequency. Furthermore, a biological cause was 
discovered; the change in hESC CM beating frequency was dependent on the function of the 
voltage gated inward rectifier channel hERG.  Over the seven day stimulation period, cells 
adapted to and matched the pacing stimulus. Interestingly the increased beating frequency did 
not greatly change the profile of each contraction, but primarily affected the frequency of 
contractions. This increased contraction frequency helped organize the contractile apparatus in 
the cell, and brought about gene expression changes in related structural proteins. Further 
expression level changes were found in cardiogenic differentiation markers, suggesting further 
development into ventricular myocytes. Microarray analysis identified the voltage gated inward 
rectifier potassium channel (KCNH2) as a gene highly associated with differential electrical 
stimulation. Further investigation showed increased protein amounts in stimulated cells. When 
blocked with a specific channel blocker, the increase in beating frequency could be reduced, but 
also rescued when the channel blocker was washed out, demonstrating a causal relationship 
between KCNH2 channel function and intrinsic beating frequency of electrically stimulated 
hESC CM EBs.  
The advent of hESC derived CMs presents a novel pathway to ameliorate heart disease 
burden by therapeutic utilization of these cells. However, key obstacles such as tissue 
organization, cellular hypertrophy, and electrical host integration need to be overcome to realize 
the use of this cell population for therapeutic purpose.  Various modalities have been successful 
in maturing neonatal rat cardiomyocytes, including the use of electrical stimulation and 
mechanical stretch to create organized cardiac subunits, with improved linearity, force 
generation and pharmacologic responsiveness. Despite these successes, the application of these 
techniques to the maturation of hESC derived CMs for tissue formation have been limited. 
Furthermore, the problem of electrical integration remains open, since the addition of cells with 
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unmatched intrinsic beating frequencies may induce arrhythmias in the host myocardium. 
Electrical induction using a biomimetic electrical stimulus therefore has the potential to guide the 
development of electrical integration of hESC CM for therapeutic utility by preconditioning cells 
or tissues allowing enhanced integration when implanted.  
Electrical signals are a unique stimulus found in the developing heart, and conductivity 
persists as a major effector for contractile function. Despite this pervasiveness of this 
phenomenon, there have been limited studies directly investigating the use of electrical field 
generation as a biomimetic stimulus to modulate hESC CM function. We used carbon electrodes 
to create a transient electric field to depolarize the hESC CMs, leading to triggered synchronous 
contraction which induced changes in the fundamental electrical parameters of the hESC CMs.  
This phenomenon may be a result of the relative plasticity of the newly differentiated 
cardiomyocytes, consistent with studies showing adaptability of hESC CMs to ultimately 
integrate with host myocardium in an in vivo setting. 
To further support the idea that hESC-CMs respond to electrical stimulation, the 
multitude of genes in the microarray analysis which changed in response to the frequency of 
stimulation suggest that electrical stimulation was a powerful stimulus affecting multiple systems 
and pathways in the developing hESC CMs. This large search of potential effectors resulting 
from the external field stimulus led to the identification of the gene KCNH2 and its protein 
product hERG, as a critical protein involved in the maintenance of differential beating 
frequencies. This channel, canonically responsible for the repolarization of the cardiac cell, 
might permit for a higher intrinsic beating frequency due to increased repolarization. The 
blockade of the channel using the inhibitor E-4031 showed a specific effect on the group which 
had higher expression of the channel, further demonstrating that the effect is unique to KCNH2 
function and less likely non-specific.  
Structural organization, fate specification, and cardiac protein expression of hESC CMs 
are of high importance in creating a robust cell based therapy. We describe the novel effect of 
electrical field stimulation on conditioning hESC derived CMs. The stimulus caused improved 
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protein organization and ultrastructure, altered genetic expression programs of many cardiac 
genes, and allowed control over fundamental beating frequencies. This validates electrical field 
stimulation as a biomimetic cue to study and manipulate the development and phenotypic 
maturation of hESC CMs. This stimulus however, also has the unique capacity to control and 
condition the intrinsic beating rate of differentiated cardiomyocytes – which we believe may be 




Aim 2: Multicellular Function: Micropatterned Three-Dimensional Hydrogel 
System to Study Human Endothelial-Mesenchymal Stem Cell Interactions 
ABSTRACT 
The creation of vascularized engineered tissues of clinically relevant size is a major 
challenge of tissue engineering. While it is known that endothelial and mural vascular cells are 
integral to the formation of stable blood vessels, the speciﬁc cell types and optimal conditions for 
engineered vascular networks are poorly understood. To this end, we investigated the 
vasculogenic potential of human mesenchymal stem cell (MSC) populations derived from three 
different sources: (a) bone marrow aspirates; (b) perivascular cells from the umbilical cord vein; 
and (c) perivascular cells from the umbilical cord artery. Cell populations were isolated and 
identiﬁed as MSCs according to their phenotypes and differentiation potential. Human umbilical 
vein endothelial cells (HUVECs) were used as a standard for endothelial cells. A novel co-
culture system was developed to study cell–cell interactions in a spatially controlled three-
dimensional (3D) ﬁbrin hydrogel model. Using microﬂuidic patterning, it was possible to 
localize hydrogel-encapsulated HUVECs and MSCs within separate channels spaced at 500, 
1000 or 2000 µm. All three MSC populations had similar expression proﬁles of mesenchymal 
cell markers and similar capacity for osteogenic and adipogenic differentiation. However, bone 
marrow-derived MSCs (but not umbilical vein or artery derived MSCs) showed strong distance-
dependent migration toward HUVECs and supported the formation of stable vascular networks 
resembling capillary-like vasculature. The presented approach provides a simple and robust 
model to study the cell–cell communication of relevance to engineering vascularized tissues. 
 
INTRODUCTION 
Normal tissue function requires vascular supply of oxygen and other nutrients. 
Unraveling the mechanisms of new blood vessel formation would offer therapeutic solutions a 
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large variety of disorders that can be treated using implanted cells and engineered tissues
53
. In 
particular, immediate and substantial vascularization of implanted tissues is critical for their 
survival and function 
54
, due to the limitations in oxygen and nutrient supply
55
. During culture, 
tissue constructs can be supplied with nutrients by medium perfusion
56
. However, vascular 
ingrowth in vivo is usually too slow to ensure graft survival
57
. 
One approach to provide functional blood supply would be the in vitro creation of 
vascular infrastructure that could anastomose with the host vasculature
55
. In general, a better 
understanding of the interplay between the cells, signalling molecules and the physical 
microenvironment is necessary to develop effective techniques for vascularization
58
. Previous 
studies have used microtechnologies to probe the angiogenic microenvironment
59, 60
, with control 
of cell positioning
16
 and focus on the effects of cytokines and smooth muscle cells on endothelial 
sprouting in these studies
14
. 
Endothelial cells (ECs) self-assemble into vascular tubes when surrounded by 
extracellular matrix
61
 and exposed to angiogenic factors
62
. To complete the process of new blood 
vessel formation, ECs must functionally interact with mural cells, such as pericytes or vascular 
smooth muscle cells (SMCs) that in turn provide for vascular maturation and stability
63
. 
In vitro models of angiogenesis provide an excellent tool for studying cell-cell 
interactions in the context of paracrine and autocrine signaling, extracellular matrix, and 
heterotypic cell-cell contacts
16, 64-67
. Growth factors released from ECs induce the recruitment of 
MSCs along angiogenic sprouts
68, 69
. Upon contact with ECs, mesenchymal precursors from 
bone marrow (but not from adipose tissue) differentiate into pericyte cells, by processes 
involving local activation of transforming growth factor (TGF)-β 64, 65 and resulting in EC 
quiescence
70, 71
 and ECM assembly
61, 72
. These studies have shown that MSCs from certain 








MATERIALS AND METHODS 
Cell isolation 
HUVEC and MSC cell populations from umbilical cord vein (UCV) 
Fresh umbilical cords (UC) of term delivery were processed according to the protocol 
approved by the Institutional Review Board. Endothelial and MSC-like cells were harvested by a 
standard protocol for human umbilical vein endothelial cell (HUVEC) isolation
75, 76
. Briefly, the 
umbilical cord segment was disinfected in 70% ethanol and rinsed with phosphate-buffered 
saline (PBS; Gibco, USA). The vein lumen was then infused with PBS, 0.1% type VI 
collagenase solution (Sigma, USA) and the cord segment was clamped at both ends. Enzymatic 
digestion at 37°C was performed for 15 min. The cell suspension was collected by extensive 
washing with PBS and pelleted by centrifugation at 250 g for 5 min. The cell pellet was 
suspended in endothelial cell medium (EGM-2; Cambrex, USA) and plated in 75 cm
2
 tissue 
culture flasks. Heterogenous culture of attached cells was subsequently sorted by florescence 
activated cell sorting (FACS). 
MSC-like cells from umbilical cord artery (UCA) 
Cells from the vessel wall of the UCA were isolated by tissue explant method
77
. Briefly, 
the segment of the artery was extracted and the surrounding tissue was removed. The 
perivascular tissue was dissected into small pieces (1-2 mm) and after the tissue explants 
attached to a Petri dish, the culture medium was added. The MSC culture medium consisted of 
Dulbecco’s Modified Eagle’s Medium–high glucose (DMEM-HG; Gibco), 10% fetal bovine 
serum (FBS; Gibco), 1% Penicillin-Streptomycin solution (Pen-Strep; Gibco) and 5 ng/mL 
bFGF. Cells that spread out of the explants were harvested by trypsin/EDTA (Sigma, USA) and 
reseeded at the density of 7,000 cells/cm
2
. EGM-2 was used for later cultures. 
MSC from bone marrow 
Cryopreserved mononuclear cells (Cambrex, USA) were processed according to the 




 in MSC culture medium. Non-adherent cells were removed with subsequent media 
changes and the adherent cells were cultured to 80% confluence. Subconfluent cells were 




Fluorescence-activated cell sorting 
Fluorescence activated cell sorting (FACS) by MoFlo high-speed cell sorter (Dako, Italy) 
or BD FACSAria Cell Sorting System (BD Biosciences, USA) was performed on 
morphologically heterogeneous UCV-derived cells. Confluent cells were harvested by 
trypsin/EDTA, pelleted and resuspended at the concentration of 10
5
 – 106 cells in 100 µL of 
PBS. Cells were stained with anti-human CD90 (Thymocyte differentiation antigen-1 Thy-1) 
conjugated with R-Phycoerythrin (RPE) (Dako, Italy) for 30 min, or indirectly labelled with 
mouse anti-human CD90 for 20 min (Millipore, USA), washed with PBS and incubated for 15 
min with the secondary antibody goat anti-mouse immunoglobulin G (IgG), fluorescein-
isothiocyanate (FITC) conjugate (Millipore, USA). Labelled cells were washed with PBS, passed 
though 40 µm cell strainer, and the cell pellet was resuspended in PBS at the density of 10
6
 cells 
per 100 µL for sorting. CD90 positive and negative populations were gated and sorted into 
collection tubes. Cell pellets were resuspended in EGM-2 medium and plated in tissue culture 
flasks at the density of 8,000 cells/cm
2
. The two sorted cell populations, CD90+ and CD90-, 
were further expanded in EGM-2 medium and characterized to verify the MSC character of 
CD90+ cells and the endothelial character of CD90- cells. CD90+ UCV-derived cells were 
referred to as MSC-like cells and their MSC character was evaluated with phenotypic 
characterization and multilineage differentiation studies. 
 
Differentiation Study 
MSCs (passage 3) and the perivascular MSC-like populations from UCV and UCA 
(passages 6, 7) were treated with induction media as described below to stimulate their 
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osteogenic and adipogenic differentiation. Cells cultured in MSC culture medium were used for 
control. The medium was changed two times a week and cell differentiation was evaluated over 
3 weeks of cultivation. 
Adipogenic Differentiation 
Adipogenic differentiation was induced on confluent cells by adipogenic medium 
containing DMEM-HG, 10% FBS, 1 μM dexamethasone (Sigma, USA), 5 μg/ml recombinant 
human insulin (Sigma, USA), 0.5 mM 3-isobutyl-1-methyl-xanthine (IBMX; Sigma, USA), 0.2 
mM indomethacin (Sigma, USA) and 1% Pen-Strep. Adipogenic cell differentiation was 
confirmed by Oil Red O staining. After 1, 2 and 3 weeks of differentiation, cells were fixed with 
4% formaldehyde for 1 hour, rinsed with distilled water and stained with a working solution of 
0.5% Oil Red O (Sigma, USA) for 20 min. Intracellular accumulation of lipid-rich vacuoles was 
visualized by light microscopy and the images were taken with Qimage colour camera. 
Osteogenic Differentiation 
Osteogenic differentiation was induced by culturing confluent cells in osteogenic medium 
containing DMEM-HG, 10% FBS, 100 nM dexamethasone (Sigma, USA), 10 mM β-
glycerophosphate (Sigma, USA), 0.1 mM ascorbic acid-2-phosphate (Sigma, USA) and 1% Pen-
Strep. Mineralized matrix was stained by von Kossa after 3 weeks of culture. The cells fixed in 
4% formaldehyde were incubated in 5% silver nitrate (Sigma, USA) for 1 hour under intense 
light, and incubated in 3% sodium thiosulfate (Sigma, USA) for 5 min to develop the signal. 
Quantitative determination of total calcium was done using the colorimetric Calcium (CPC) 
LiquiColor assay (Stanbio Laboratory, USA). Calcium was extracted by 5% trichloroacetic acid 
(200 μL per P48 well) overnight and determined spectrophotometrically at 550 nm following the 
reaction with o-cresolphthalein complexone. All assays were done in triplicate and expressed as 
absolute values (μg of Ca2+ per well) according to the standard curve. 
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Microfabrication of the mold 
The design of the desired hydrogel micropattern was created in AutoCAD (Autodesk 
Inc.) and printed at high-resolution (CAD/Art Services, Inc., USA). The pattern consisted of two 
parallel channels, 1 cm long and 1000 μm wide, with a spacing of 500, 1000 or 2000 μm. The 
generated transparency mask was used in photolithography of SU-8 50 photoresist (Microchem, 
USA). The photoresist was spin-coated onto the glass wafer (Laurell). 
The master was developed by immersion of the SU-8 wafer into developer propylene 
glycol methyl ether acetate (PGMEA; Sigma, USA) under strong agitation for 10 minutes to 
remove the non-crosslinked photoresist, and used for replica molding of degassed elastomer mix, 
composed of poly(dimethylsiloxane) (PDMS) and the curing agent in ratio 10:1 (Sylgard 184 
Silicone elastomer kit; Dow Corning, USA). The curing of PDMS was conducted in an oven at 
60°C for 2 hours. Solid PDMS was peeled off the master, the individual microfluidic molds were 
cut out with holes punched for fluid inlets. Plasma oxidation was used to render the PDMS mold 
surface hydrophilic, as required to pull the hydrogel through the channels via capillary action. 
The molds were plasma cleaned for 20 s, with the pattern side up. The PDMS surface was then 
blocked using a 5% solution of FBS (Gibco) in distilled water. 
 
Micropatterning of cell-loaded hydrogels 
The elastic PDMS mold was used to pattern the 3D cell-loaded hydrogel channels onto 
tissue culture plastics. Fibrin hydrogel was generated by polymerization of fibrinogen (Fraction I 
from pig plasma; Sigma, USA) by thrombin (from bovine plasma; Sigma, USA). The PDMS 
molds were reversibly sealed on 100 × 20 mm culture plates (BD Falcon, USA), with the 
patterns facing down. Endothelial cells and MSC populations (passage 3 for bone marrow-
derived MSCs, passage 6 for UCVs, and passage 7 for UCAs) were encapsulated into separate 
channels, as follows. An endothelial cell pellet was suspended in a thrombin solution (8 U/mL) 
at high cell density, approximately 2 × 10
6
 cells per 100 μL and mixed with a 1% fibrinogen 
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solution in ratio 1:5. The suspension was immediately injected into one of the microchannels, 
and the suspension of one of the MSC populations was injected into the opposite channel using 
the same procedure. Approximately 20 μL of cell suspension was used per channel. The 
fibrinogen was allowed to polymerize for 15 minutes. The PDMS mold was carefully taken off 
the culture dish leaving the patterned hydrogel with encapsulated cells attached to the plastic 
surface. The hydrogel channels were then encapsulated in another layer of fibrin to provide 
uniform hydrogel matrix. 
 
Cell migration assay 
Mesenchymal cell populations from the three sources were assessed for their capacity to 
migrate through fibrin toward ECs and stabilize the vascular network. Cell sprouting was 
monitored within the first three days after encapsulation to assess chemotactic effect between the 
cells. Bright-field images of the channels were acquired, and a single cell sprout length was 
measured as the perpendicular distance of mesenchymal cell migration from their channel edge 
toward the opposite channel containing HUVECs, at a 200X magnification, using Metamorph 
Software caliper. For each cell type, the average and total lengths of all the sprouts in each image 
(showing 330 μm of the channel length) were determined. Three images were evaluated for each 
experimental condition, at 24 hr intervals. Single channels of mesenchymal cell populations in 
fibrin matrix were used as controls. 
 
Live/dead assay for visualizing vascular network formation 
The Live/Dead Viability/Cytotoxicity Kit for mammalian cells (Invitrogen) was used for 
simultaneous determination of live and dead cells. The co-culture systems were stained two 
weeks after encapsulation according to the manufacturer’s protocol. Live cells converted the 
virtually nonfluorescent calcein AM to the intensely green fluorescent calcein, while ethidium 
homodimer (EthD-1) bound to nucleic acids of cells with damaged membranes, thereby 
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producing a bright red fluorescence in dead cells. The Live Dead staining was effective in 
visualizing vascular network formations due to its ability to highlight living cells. 
 
Immunofluorescence staining of the starting cell populations 
The cells were characterized after three to six passages by immunofluorescence staining. 
Cells on cover glasses in 12- well culture plates were fixed with 4% formaldehyde for 15 
minutes and washed with PBS. For intracellular antigen staining cell permeabilization with 0.1% 
Triton X-100 (Sigma) in PBS for 10 minutes was performed. After 1 hour-incubation in blocking 
serum (10% goat serum; Gibco, USA) cells were labeled with a primary antibody diluted 1:100 
in PBS for 1 hour at room temperature. The following mouse anti-human antibodies were used: 
anti-CD90 (Millipore, USA), anti-CD105 (Abcam, USA), anti-CD31 (Sigma, USA) and anti-
Smooth Muscle Actin α-isoform (α-SMA; Invitrogen, USA), anti-von Willebrand Factor (vWF, 
Invitrogen, USA). After several washings with PBS the cells were incubated with the secondary 
antibody anti-mouse IgG-FITC at 1:100 dilution in PBS for 30 minutes at room temperature. 
Finally, cells were washed with PBS, cell nuclei were counterstained with 4′,6-diamidino-2-
phenylindole (DAPI; Sigma) and cover slips were mounted using Fluoromount-G (Southern 
Biotech, USA). 
 
Immunofluorescence staining of hydrogel-encapsulated cells 
Micropatterned co-cultures of cells were immunostained for α-SMA and von Willebrand 
factor, with incubation times adjusted for the presence of the surrounding fibrin matrix. The 
samples were fixed with 4% formaldehyde for 30 minutes, rinsed and the cells were 
permeabilized with 0.1% Triton X-100 in PBS for 20 minutes. After incubation in the blocking 
serum (10% goat serum) for 2 hours, the mixture of primary antibodies: mouse anti-human α-
SMA and rabbit anti-human von Willebrand factor (Sigma, USA) diluted 1:200 in PBS was 
added. Incubation was done overnight at room temperature under slow agitation. The samples 
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were washed three times with PBS for 1 hour, stained with secondary antibodies: goat anti-
mouse IgG-FITC and goat anti-rabbit IgG-RPE (Sigma, USA) at 200X dilution in PBS for 3 
hours at room temperature, and washed three times with PBS (for 1 hour each time). Cell nuclei 
were counterstained with DAPI and the samples were observed under the fluorescent microscope 
immersed in PBS without any mounting. 
 
Statistical analysis 
The measured values were expressed as Average ± Standard Deviation. Statistical 
evaluation by unpaired t-test was used to assign statistically significant differences between the 




Cell populations were characterized for the expression of the MSC markers (CD90, 
CD105), an early SMC marker (α-SMA) and an endothelial cell marker (CD31). The CD90+ 
fractions of mesenchymal cells from unmbilical vein, umbilical artery and bone marrow, 
designated as UCV, UCA and MSCs, respectively, had similar expression profiles of 
mesenchymal cell markers (Fig IV-1). All cells were uniformly positive for CD90 and CD105, 
partially positive for α-SMA, and negative for CD31, suggesting that the UCV and UCA 
perivascular cell populations are of a mesenchymal phenotype. As expected, HUVECs were 
strongly positive for CD105 and CD31, but negative for CD90 and α-SMA (Fig IV-2), 
consistent with the endothelial phenotype. 
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Osteogenic and adipogenic capacity of mesenchymal cell populations 
To further assess the mesenchymal character of the UCV and UCA cells, their potential 
for differentiation into adipogenic and osteogenic lineages was compared to that of bone marrow 
derived MSCs. In all adipogenic cultures, the cells changed their morphology from fibroblast-
like to large, rounded cells containing intracellular lipid vacuoles (Fig IV-2A). In contrast, non-
treated cells remained fibroblast-like and no lipid accumulation was observed. These results 
demonstrated that similarly to bone marrow derived MSCs, the UCV and UCA cells exhibit 
adipogenic differentiation potential. 
 
 
Figure IV-1. Phenotypic characterization of starting cell populations. Immunoﬂuorescence 
staining of umbilical cord vein (UCV) and artery (UCA) MSC-like cells, bone marrow-derived 
MSCs (MSC) and HUVECs (HUV) for mesenchymal stem cell markers CD90 and CD105, early 
smooth muscle cell marker α-SMA (SMA) and endothelial cell marker CD31. Magniﬁcation, 
×100; calibration bar = 200 µm 
 61 
In osteogenic cultures, the accumulation of mineralized matrix was demonstrated by von 
Kossa staining after three weeks of treatment (Fig IV-2A), whereas no deposition was observed 
in the respective controls. Calcium deposits were more broadly distributed in cultures of MSCs 
in comparison to the UCV and UCA cells, where the depositions were more concentrated and 
coincided with the regions of multilayered cell condensations. The elevated calcium content in 
osteogenic cultures was further confirmed by the calcium colorimetric assay that showed a 
gradual increase of calcium content over the course of three weeks, in contrast to negligible 
levels of calcium in cultures of MSCs in EGM-2 medium (Fig IV-2B). After 3 weeks of 
osteogenic treatment, calcium content was slightly but not significantly higher in cultures of 
MSCs as compared to UCV and UCA cells. However, all three cell populations showed 




Figure IV-2. Differentiation of mesenchymal stem cells into adipogenic and osteogenic 
lineages. (A) Oil red O staining, visualizing lipid vacuoles in the cytoplasm of adipogenic-
treated cells, and von Kossa staining (scale bar = 1 mm) of osteogenic-treated cultures of 
umbilical cord vein (UCV) cells, umbilical cord artery (UCA) cells and bone marrow-derived 
mesenchymal stem cells (MSCs) showing Ca
2+
 deposits after 3 weeks of treatment (scale bar = 
100 µm). The respective untreated controls are shown in the insets. (B) Bar charts showing Ca
2+ 
contents in the cultures treated with EGM-2 (EGM), MSC culture medium (DMEM) and 
osteogenic medium (OST) after 3 weeks of treatment. ∗∗ Statistically signiﬁcant difference 
between the osteogenic and the control cultures (p < 0.001) 
 
Taken together, the data in Fig IV-2 show that the mesenchymal stem cell populations, 
although obtained with different number of passages (P3 for bone marrow MSCs, P6 for UCVs, 
P7 for UCAs), responded rather similarly to adipogenic and osteogenic induction, as verified by 




content (for osteogenic differentiation). In contrast, control cells from all groups lacked to 





Figure IV-3. Micropatterned hydrogel system for 3-dimensional co-culture of mesenchymal 
and endothelial cells. A) Micropatterned fibrin channels loaded with HUVECs (left channel) 
and MSCs (right channel) with the distances between channels of 500, 1000 and 2000 μm. B) 
Encapsulated HUVECs labelled with red intracellular dye (left channel) and MSCs labelled with 
green dye (right channel). 
 
Co-cultures of mesenchymal and endothelial cells in micropatterned hydrogel 
Microfluidic patterning techniques were employed to arrange cell-loaded hydrogel into 
two parallel channels spaced apart at 500 μm, 1000 μm or 2000 μm) (Fig IV-3A). Fibrin was 
used as a hydrogel, because of its appropriate biochemical and mechanical properties as a 3D 
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matrix for angiogenensis in vitro
78
, as well as due to its unique characteristic of rapid assembly, 
which was desirable for the generation of co-cultures. Fluorescent labelling of HUVECs and 
mesenchymal cells with red and green dyes, respectively, confirmed that it was possible to 
encapsulate the different cell types into separate fibrin channels (Fig IV-3B). 
 
Directional migration of mesenchymal cells 
Bone marrow derived MSCs demonstrated strong distance-dependent directional 
migration toward HUVECs, with highest extent of sprouting when these cells were placed at the 
closest (500 μm) initial distance from HUVECs (Fig IV-4). The extent of sprouting decreased as 
the channel-to-channel distance increased, and became indistinguishable from the control at the 
distance of 2000 μm. The total length of sprouts forming at the 500 μm channel-to-channel 
distance was already significantly different from the control after one day of culture (4,460 vs. 
2,140 μm, respectively, p<0.05). By day 3 of culture, the total length of sprouts reached 86,800 
μm for the 500 μm channel distance, and 30,300 μm for the control MSCs cultured without 
HUVECs (p < 0.01). For the 1,000 μm channel distance, the total length of sprouts was 52,000 
μm, as compared to 30,300 μm for the control (p<0.01). These data suggest that the total length 
of sprouts depended on both the MSC-HUVEC distances and time in culture. Notably, the 
average length of sprouts was not significantly dependent on channel-to-channel distance. Taken 
together, the distance-dependent migration studies suggest that the chemotactic effects increase 




Figure IV-4. Effects of cell source, channel spacing and culture time on directed migration 
of mesenchymal cells. A) Micropatterned fibrin channels loaded with HUVECs (left channel) 
and MSCs (right channel) 500 μm apart, demonstrating sprouting of the UC vein cells (UCV), 
artery cells (UCA) and BM-derived mesenchymal stem cells (MSC) for the first three days after 
cell encapsulation in hydrogel. Light microscopy, scale bar 100 μm. B) The total lengths of 
sprouts for mesenchymal cells from different sources: UC vein cells (UCV), artery cells (UCA) 
and BM-derived mesenchymal stem cells (MSC). * statistically significant differences between 
groups (p < 0.05). 
In contrast, the UCV cells showed no distance-dependent sprouting (Fig IV-4). The total 
lengths of sprouts were in the range of 3,100 to 5,450 μm on day one, and increased to 15,200–
21,500 μm by day three. Likewise, the relative distance from HUVECs had only a modest effect 
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on directed migration of UCA cells (Fig IV-4). The distance-dependence noticed on day one 
(3,770 versus 1,870 μm, p<0.05) diminished with time in culture (12, 800 versus 9,050 μm, 
p>0.05). Taken together, these results demonstrate significant differences in the migration 
behaviour of MSC populations in co-culture with the HUVECs. While MSCs exhibited strong 
chemotactic migration, UCA cells showed only moderate responsiveness, and UCV cells were 
unresponsive to the presence of HUVECs. 
 
Vascular network formation 
Bone marrow derived MSCs supported the formation of long, highly branched and 
interconnected tubular structures that resembled capillary networks. The initial distance between 
the MSCs and HUVECs did not affect vascular network formation. Once the MSCs came into 
direct contact with endothelial tubular structures (within 3–8 days), they were able to stabilize 
them irrespectively of the starting distance. The stabilized capillary-like networks were 
maintained in culture for more than two weeks, while tube-like structures formed by HUVECs 
alone gradually regressed. These vascular networks were also considerably different from the 
MSC sprouts formed without the contact with HUVECs. Even though the MSC sprouts were 
elongated and branched, the perimeter was distinctly smaller in comparison with the stabilized 
vascular tubes (Fig IV-5B). 
In contrast to bone marrow derived MSCs, the UCV and UCA cells did not demonstrate 
stabilizing effects on endothelial tubular structures. Interestingly, when these cells populations 
reached HUVECs, the pre-formed tubular structures reorganized into round-shaped cell clusters. 
However, the UCV cells seemed to support the survival of HUVECs, even if they did not 





Figure IV-5. Stabilization of the vascular network by mesenchymal stem cells. Live/dead 
fluorescent staining of the HUVEC channel (right panels) and the MSC channel (left panels) 
after two weeks of culture. The images demonstrate cell organization in co-cultures of HUVECs 
and mesenchymal cells from various sources (UCV, UCA, bone marrow MSC). Stabilized 
vascular network is seen in the co-culture of HUVECs with MSCs, but not with UCV and UCA 
cells. Fluorescent microscopy, scale bar 500 μm. 
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Differentiation of hydrogel-encapsulated mesenchymal cells into SMC-pericyte lineages 
The expression of the early marker of SMC differentiation, α-SMA, showed remarkable 
differences in terms of the localization and relative quantity of α-SMA positive cells over the 
course of cultivation (Fig IV-6). On day 3 after encapsulation, only scarce α-SMA positive 
mesenchymal cells were observed. After 14 days of culture, strong α-SMA staining was 
observed at the sites of contact between HUVECs and migrated bone marrow MSCs, while only 
scarce α-SMA+ cells were present elsewhere. The staining revealed well-organized distribution 
of α-SMA+ cells that were co-aligned with endothelial tubular structures (Fig IV-6). Both 
controls of HUVEC and MSC cells alone showed no SMA staining by day 14 (Fig IV-6B). The 
expression of α-SMA and the co-alignment with endothelial tubes indicated pericyte-like manner 
of bone marrow MSCs (but not the UCA and UCV cells) on stabilization of the vascular 
networks, with cell-cell contact playing a major role in the process. 
 
DISCUSSION 
Understanding the process of new blood vessel formation has become the principal, yet 
challenging, objective of recent research activities
57
. We present a novel 3D micropatterned 
hydrogel model designed to study interactions between endothelial and mesenchymal cell 
populations, both important players in neovascularization
73
. Hydrogel micropatterning allows the 
spatial positioning of these two cell populations at controllable distances (500, 1000 or 2000 
μm). The proposed hydrogel model was developed to explore the nature of HUVEC-MSC 
communication and to compare the vasculogenic potential of different mesenchymal cell 
populations (from bone marrow, umbilical vein and umbilical artery). These cell populations 
were characterized for their phenotype, differentiation potential and capacity to directionally 




Figure IV-6. The progression of cell sprouting in the hydrogel co-culture system. A) Co-
culture of HUVECs with bone marrow MSCs encapsulated within the separate channels at a 500 
μm distance. Bright-field images show cell sprouting at days 3 and 14, as MSCs migrated 
towards HUVECs. Light microscopy, scale bar 250 μm. B) The corresponding 
immunofluorescence stains. Green staining demonstrates α-SMA+ cells; nuclei are stained blue 
with DAPI. C Overlay of the bright-field and immunofluorescence images at day 14 (a), 
illustrating co-alignment of α-SMA+ cells with the endothelial tubular structures. No α-SMA+ 
cells were present in pure cultures of HUVECs (b) and MSCs (c). Red staining shows von 
Willebrand factor positive HUVECs (b). Scale bar: 500 μm. 
 
Previous studies have suggested that growth factors released from endothelial cells 
induce migration of undifferentiated mesenchymal cells toward endothelial cells. We 
hypothesized that EC-secreted factors establish a distance-dependent chemotactic gradient in 
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fibrin matrix that stimulates directional migration of mesenchymal cells. The model enables 
study of paracrine interactions, by measuring the extent of directional migration of mesenchymal 
cells as a function of their distance from HUVECs and time in co-culture. 
All three mesenchymal cell populations (MSC, UCV and UCA, Fig IV-1 & V-2) 
demonstrated capacity for sprouting in fibrin hydrogel (Fig IV-5). Quantitative data revealed 
significant differences in their distance-dependent responses to HUVECs (Fig IV-4 & Fig IV-5). 
MSCs from bone marrow demonstrated strong distance-dependent response, as the migration 
rate was highest at the closest (500 μm) initial distance from HUVECs, and decreased with the 
increasing distance (Fig IV-4). This behaviour is consistent with the model where endothelial 
cell-secreted chemokines regulate the migration process, in a concentration-dependent manner. 
In contrast to MSCs, UCV and UCA cells migrated relatively independently of the initial 
distance from HUVECs (no statistical difference was observed in either case). These results 
indicated that only bone marrow derived MSCs demonstrate strong chemotactic responses. 
Further studies should confirm the specific mechanism of mesenchymal cell migration to explain 
the different chemotactic responses of different mesenchymal cell populations to the proximate 
endothelial cells. 
HUVECs are known to readily organize themselves into tubular structures
78
, with the 
formation of intracellular vacuoles being an important step in the capillary lumen creation
61, 79, 80
. 
Our culture system provided a suitable microenvironment for EC assembly into tubular network 
in terms of biochemical cues and biomechanical properties (Fig IV-3 - V-6). As in other 
studies
66, 67
, the tubular network gradually regressed if not stabilized by the surrounding 
perivascular cells. In contrast, bone marrow MSCs greatly supported the formation of stable 
vascular networks, with long and highly branched tubular structures resembling a capillary 
network, for more than two weeks of culture (Fig IV-5). 
The initial distance between the two cell types did not considerably affect the vascular 
network formation, even though MSCs reached HUVECs at different stages of their tubular 
assembly. In contrast to bone marrow MSCs, the UCV and UCA cells did not exert stabilizing 
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effect on EC tubular structures, and instead caused the reorganization of HUVECs into cell 
clusters (Fig IV-5). Still, UCV cells better supported the survival of endothelial cells, even if 
they did not stabilize endothelial tubules, whereas UCA cells did not exert any supporting effect 
on endothelial cells. 
Because UCV and UCA cell populations are derived from a perivascular tissue of large 
vessels, their adopted specialization could make them less efficient in supporting the 
microvasculature formation. Nonetheless, these two perivascular cell populations, especially 
UCA cells, exhibited pluripotency and outstanding 3D growth, with aligned and densely packed 
cells when cultured in a 3D fibrin hydrogel. This suggests their potential for some other tissue-
engineering applications, where organized and highly condensed growth of cells is required, such 




Since the regressed tubular structures in HUVEC cultures did not express α-SMA, it is 
reasonable to assume that the surrounding MSCs were the source of α-SMA+ cells. Because 
bone marrow MSCs did not express α-SMA in early co-cultures, neither in the later cultures at 
the sites with no direct contact with ECs, their differentiation toward vascular SMC/pericyte 
lineages was presumably induced by direct contact with endothelial tubes. Our study supports the 
notion that mesenchymal cells function as vascular pericytes
67, 73
. According to previous studies, 
local activation of TGF-β could be involved, as the same mechanism directs the differentiation of 
embryonic mesenchymal precursors 10T1/2 toward SMC lineage
64, 65
. 
In summary, the hydrogel co-culture system developed in this study could serve as a 
novel platform for studying vasculogenesis under spatially controlled conditions. The ability to 
precisely define the arrangement of different cell types in a 3D hydrogel system provides a 
simple and robust model for studying cell-cell interactions as a function of distance between the 
two cell types, without using elaborate and expensive equipment. When applied to interactions 
between the populations of mesenchymal and vascular cells, this model enabled screening of the 
vasculogenic and supportive roles of different cell populations. This approach has potential for a 
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variety of applications, such as drug models, and vascular biological studies that can lead 




Aim 3: Multicellular Function : Assembly of Complex Cell 
Microenvironments Using Geometrically Docked Hydrogel Shapes 
ABSTRACT 
Cellular communities in living tissues act in concert to establish intricate 
microenvironments, with complexity difficult to recapitulate in vitro. We report a method for 
docking numerous cellularized hydrogel shapes (100 – 1,000 µm in size) into hydrogel templates 
to construct three-dimensional cellular microenvironments. Each shape can be uniquely designed 
to contain customizable concentrations of cells and cytokines, and can be placed into any spatial 
configuration, providing extensive compositional and geometric tunability of shape-coded 
cell/cytokine patterns using a highly biocompatible hydrogel material. Using precisely arranged 
hydrogel shapes, we investigated migratory patterns of human mesenchymal stem cells and 
endothelial cells. We then developed a finite element gradient model predicting chemotactic 
directions of cell migration in micropatterned co-cultures that were validated by tracking ~2,500 
individual cell trajectories. This simple yet robust hydrogel platform provides a comprehensive 
approach to the assembly of three dimensional cell environments. 
 
INTRODUCTION 
Biological tissues are comprised of cellular “building blocks” that cooperate to provide 
tissue-specific functions
17, 18, 82-85
. Specific cells, cytokines, and their geometric assembly 
establish a biological system, whether it is a vascular network surrounded by parenchymal 
cells
86
, a developing tissue
8, 87-89
, or a metastatic tumor
90-94
. In vitro culture systems designed to 
control the three-dimensional (3D) presentation of multiple cells and cytokines in a biologically 
relevant matrix are needed to faithfully recapitulate intricate biological niches
95-101
. Previous 
attempts to assemble complex tissue structures in vitro lacked the specificity and yield to control 
large numbers of cells and soluble factors
20, 100, 101




, and used matrices without adequate biological function
104-109
. Therefore, spatial 
microenvironmental control of biological systems has been difficult to achieve. Such control is 
important in many processes, including the migratory formation of vasculature, where gradient 
patterns dictate growth of vascular sprouts. For example, endothelial cell (EC) stabilization via 
mesenchymal stem cell (MSC) interactions is known to facilitate the maturation of blood vessels 
impacting many physiologic systems, from tumors to engineered tissues
74, 110, 111
. Recent studies 
clearly showed the importance of micro-scale gradients for vasculogenesis
15, 112, 113
. 
We report a novel method by which micro-sized 3D hydrogels are shape-coded for their 
biological and physical properties and docked by iterative sedimentation into shape-matching 
hydrogel templates. Microenvironmental niches were fabricated using gelatin methacrylate 
(GelMA), a modified native protein with excellent biocompatibility, tunable mechanical 
properties, and micrometer-scale patterning resolution
114, 115
. GelMA was molded into diverse 
geometric shapes with dimensions of 100 – 1,000 µm, after encapsulating cells or cytokines of a 
desired type and concentration. This way, biological niches were shape-coded, and various 
shapes could be assembled into collective structures with emergent properties. 
Shape-coded cell niches were docked into hydrogel templates containing congruent wells 
of different geometries using gravity-based sedimentation. Over multiple sedimentation events, 
docked shapes were shear protected and remained in their wells, while mismatched shapes were 
resuspended to settle again. The geometric uniqueness of each shape enabled exclusivity and 
specificity of docking into congruent wells, allowing simple yet precise fabrication of geometric 
patterns mimicking native cell microenvironments. These techniques were used to form radially 
organized 3D patterns to study sprouting and the homing of MSCs to ECs, by using the diffusive 
signaling patterns to dictate spatial orientation of cell migration. A finite element gradient model 
was built by accounting for the repelling and attracting forces originating from the docked 
hydrogels. Large numbers of single cells were tracked using advanced image processing 
algorithms to validate the dependence of cell migration on the spatial gradient. 
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MATERIALS AND METHODS 
Cell Culture 
Human Mesenchymal Stem cells (MSC) were isolated from fresh bone marrow aspirates 
obtained from Cambrex Life Sciences as previously described
15, 116
, grown in high glucose 
Dulbecco’s modified Eagle’s medium (DMEM) with 10% FBS and 1% penicillin/streptomycin 
(all from Invitrogen) with 0.1 ng/ml bFGF (Invitrogen), and expanded to passage 8 or lower. 
Human umbilical vein endothelial cells (HUVEC) were isolated from post-natal discarded 
umbilical veins following the protocol IRB-AAAC4839, and grown using EGM-2 Media 
(Lonza) to passage 8 or lower. Rat neonatal cardiomyocytes were harvested from day 1-2 
neonatal rats as in our previous studies
56
 under protocol AC-AAAB2757. 
 
Gelatin Methacrylate Synthesis 
Gelatin methacrylate was synthesized according to a previously published method 
114, 115
. 
Briefly, gelatin (Difco) was dissolved in PBS at a concentration of 0.1 g/mL, and 1 mL of 
methacrylic anhydride (Sigma) per gram gelatin was added dropwise to the gelatin solution over 
30 minutes. The solution was stirred, allowed to react for 1 hour at 60oC, cooled to room 
temperature, dialyzed with a 14 kDa cutoff against ultrapure water for 4 days, frozen, then 
lyophilized. 
 
Micromolding of Hydrogel Shapes and Templates 
Poly(dimethylsiloxane) (PDMS; Fisher) molds for generating the hydrogel shapes and 
wells were prepared using standard soft lithography. AutoCAD (Autodesk) was used to design 
the masks that (Cad/Art Services), and SU-8 (Microchem) photolithography was used to 
generate master molds. Specifically, molds for circle shapes were 600 µm in diameter by 500 µm 
deep, rectangles were 300 µm wide x 750 µm long x 300 µm deep, and triangles were equilateral 
with each side being 600 µm x 300 µm deep. Shapes used in the cardiomyocyte study were 100 
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µm wide x 300 µm or 1000 µm long x 100 µm deep. Each shape was generated in approximately 
400 repeating copies per batch, using a 4 cm by 2.5 cm mold. Molds for the well templates were 
fabricated using the same soft lithography technique. PDMS molds were created from the master 
patterns, washed, dried and plasma cleaned for 60 seconds.  
Hydrogel shapes were fabricated using a 10% w/v pre-polymer solution of gelatin 
methacrylate (GelMA), 1% w/v 2-hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methyl-1-
propanone (Irgacure-2959; BASF), and 1% v/v 1-vinyl-2-pyrrolidone (Sigma) in phosphate 
buffered saline (PBS; Invitrogen). For each geometric shape, a defined concentration of cells or 
cytokines was added to each pre-polymerization GelMA solution. The GelMA solution 
containing a desired concentration of specific cells or cytokines was pipetted onto the PDMS 
mold, placed on a glass slide excluding excess GelMA and exposed to UV light for 30 seconds 
(Omnicure 100, Lumen Dynamics). Following polymerization, the shapes were harvested from 
the wells by resuspension and pipetting. To generate conjugate well templates, masks with a 
specific configuration of multiple geometric shapes were used to generate the PDMS molds. The 
10% w/v pre-polymer GelMA solution was placed between the PDMS mold and a glass slide 
treated with 3-(Trimethoxysilyl)propyl methacrylate (Sigma) to permit a covalent linkage of the 
well hydrogel to the glass substrate upon polymerization. For additional specifications, please 
see Fig V-1 and Fig V-2. 
 
Sorting and Docking 
After fabrication, a mixture of geometric shapes needed for a specific experiment was 
suspended in DMEM at a concentration of ~100 shapes per mL. A suspension of the three 
canonical shapes - circle, triangle and rectangle, was pipetted on the hydrogel template 
containing a specific configuration of geometrically different wells, and allowed to settle for 1 
minute. The hydrogel template was then exposed to agitation using an orbital shaker (Innova 
4000, New Brunswick Scientific) set to 90 RPM, which allowed sufficient agitation to resuspend 
 77 
incorrectly sorted shapes, but was gentle enough to maintain shear protection for the correctly 
sorted shapes. After 1 min of agitation, the shapes were allowed to settle again for 1 min. This 
process was repeated for up to 10 cycles, by which time the well templates were occupied by 
properly docked shapes. Following sorting, excess shapes were washed away from the wells, and 
an additional layer of uncrosslinked gelatin methacrylate was UV polymerized for 30 s to 
permanently lock the sorted shapes. 
 
Shape Sorting Analysis 
A suspension containing excess amount of hydrogel shapes of any specific type was 
pipetted onto a template in form of a Cartesian grid of circles, triangles and rectangles at a 
density of 92 wells per cm2. For each shape and gel concentration, the docking specificity was 
calculated as a ratio of correctly sorted shapes and the total number of docked shapes. The 
docking yield was calculated as a ratio of the number of the docked shapes of a particular type 
and the number of congruent wells. 
 
Mechanical Testing 
The modulus of fabricated gelatin methacrylate gels were measured for 5, 10, 15, and 
20% w/v hydrogels. The equilibrium compressive Young's modulus (n=4) was determined at 
under unconfined compression under wet conditions using a modification of an established 
protocol
117
. An initial tare load of 0.2 N was applied followed by a stress-relaxation step where 
specimens were compressed at a ramp velocity of 1% per second up to 10% strain and 
maintained at the position for 1,800 s. The elastic modulus was obtained from the equilibrium 
forces measured at 10% strain, plotted as a function of hydrogel composition (% GelMA) and fit 




Circular shapes were suspended in a 100 µg/mL Texas-Red tagged 10 kDa dextran or 
Texas-Red tagged bovine serum albumin (BSA). Rectangular shapes were suspended in a 100 
µg/mL Alexa 488 tagged 10 kDa dextran or Alexa 488 tagged BSA for 8 hours to allow the 
fluorescently tagged molecules to fully diffuse into the gel (all reagents Invitrogen). Shapes were 
sorted and assembled into the template wells, and fluorescence images of the patterns were taken 
every 10 min over 100 min at the same image settings. Using MATLAB (Natick, MA), areas 
with the shapes were masked out, and fluorescence intensity of the remaining images was 
normalized to the maximum intensity of all images in the experiment. As an additional metric 
comparing 10 and 20% GelMA, the distance at which fluorescence intensity dropped below 50% 
was measured for each time point. 
 
Cardiac Contraction Analysis 
The effect of shape geometry on cell function was evaluated by encapsulating cardiac 
myocytes in rectangular shapes with two different aspect ratios: long rectangles (1:10) and short 
rectangles (1:3). Shapes with encapsulated cells were cultured for one week in DMEM. Video 
analysis was performed to determine the frequency and amplitude of macroscopic contractions. 
The amplitude of contractions was measured using ImageJ software, by finding the minimum 
and maximum distance between fixed points on the two ends of the cardiomyocyte-laden 
hydrogel shapes during each contraction cycle. The measured difference was calculated as a 
percent of total length (n=50). The frequency was measured from the number of contractions in 
the entire video per unit time (n=27). 
 
Cell Migration 
MSCs were encapsulated into circular shapes ECs were encapsulated into rectangular 
shapes at a concentration of 10
6
 cells/mL. For the migration experiments, the hydrogel template 
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contained patterns with a central circle (600 µm diameter x 750 µm deep) surrounded by four 
rectangles (300 µm wide x 750 µm long x 750 µm deep) that were spaced 750 µm from the 
center of the circle. Cells were cultured in EGM-2, and phase contrast images were taken at 
regular intervals for up to 14 days. 
 
Numerical Simulation of Diffusion Gradients 
The multi-physics software COMSOL (COMSOL AB, Stockholm, Sweden) was used to 
solve the partial differential equation (PDE) for diffusion of bioactive molecular species 
(encapsulated in hydrogel or released by the cells) over the entire domain (

 (Dc)  0, 
where D is the diffusion coefficient, and c is the cytokine concentration). We chose the whole 
template to serve as a simulation domain, because we were interested in cellular migratory 
behavior in the template and not within the shapes themselves. We assume that diffusion of 
cytokines within the shapes did not affect the gradient within the template.  The circumferential 
boundary conditions of different shapes – positive flux for the growth factor secreting cells (ECs 
as a sink) and negative flux for the growth factor consuming cells (MSCs as a source) – were 
defined using the following equation:

n N N0;N  Dc , where

n  is the normal vector and 

N0 is the constant inward flux at the boundary.  We further set the initial growth factor 
concentration at zero throughout the entire domain (

c0  0), defined the domain boundaries with 
convective flux (which denotes that the growth factor can freely diffuse in and out of the 
domain), and held the diffusion coefficient constant over the domain (

D const). To achieve 
short simulation times with high accuracy, we chose a mesh size of 2 µm in the vicinity of the 
boundaries and 10 µm in the bulk. We used “Direct (UMFPACK)” solver to solve the PDE with 
the above boundary conditions, and exported the concentration gradient vector map to compare 
with the experimental data. 
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Image Analysis of Cell Migration 
Cell migration images were processed by MATLAB to inscribe vectors quantifying their 
orientation. Images were masked to remove the area containing shapes, since the shapes gave 
obvious non-cell vectors due to edge effects. The subsequent image was smoothed using a 
reconstruction algorithm, with a close-open filtering sequence. A serial opening by 
reconstruction using disc shaped structuring elements of 2-7 pixels in diameter allowed for 
discolorations within the cell to be removed without affecting the cell boundaries, effectively 
smoothing the cell image while preserving clear edges of the cell boundaries. A Gaussian filter 
further reduced noise in the images by using a rotationally symmetric Gaussian blur for each 
pixel.  Next, the images were thresholded using a high pass filter to remove low intensity pixels 
from the background. A Sobel operator was used to accentuate cell edges, with the gradient of 
pixel intensity used to highlight the regions with large differences in pixel intensity, 
corresponding to a cell edge. A watershed transformation allowed the segmentation of each cell 
into an enclosed shape for further analysis (Fig V-11). Using built-in ImageJ functions, an ellipse 
was fit to each segmented cell, where the centroid of the ellipse demarcated the location of the 
cell and the long axis was used as the cell vector. 
 
Determination of Migration Rate 
Images were quantified for overall migration rates using vectors generated from Day 14 
images. The total distance from the circle edge to the leading migration edge was measured using 
ImageJ by connecting vectors head to tail, resulting in a total distance traveled. This analysis was 
performed for all points around the circle and averaged over time, resulting in an average 
migration rate for the MSC alone and MSC-EC co-culture groups. 
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Cell Vector Analysis 
To compare the measured angles of cell vectors with the model predictions, each cell 
location was correlated to the model by aligning the hydrogel rectangles on bright field images to 
the rectangles in the model, and scaling the distances so all of the cell images would be spatially 
compatible. Each cell vector was compared to the associated model vector and the dot product 




Heat maps were generated using a MATLAB script with the grid-fit function to derive 
the plots from the cell vector angle data. For monoculture heat maps (Fig V-7G), the angle 
between each cell vector and its associated radial vector was determined from the dot vector 
product, and plotted as a heat map (with red corresponding to 90
o
, and blue corresponding to 0
o
). 
For co-culture heat maps (Fig V-7I), the angle between the measured and modeled co-culture 
cell vectors and the co-culture model was compared to the radial diffusion model. The heat maps 
highlight in red the regions where the co-culture cell vectors showed agreement with the co-
culture diffusion model, but not the radial model. 
 
Statistics 
To compare the effect of shape geometry or hydrogel composition on the yield of shape 
sorting, 2-way ANOVA was performed (n=3, p < 0.05). Further, to compare efficiency, 2-way 
ANOVA was performed at each round of shaking (n=3, p < 0.05). To establish differences 
between the experimental groups for cardiac contraction studies, the non-parametric, Wilcoxon 
rank sum test (also known as Mann-Whitney U test) was used (n=27-50, α = 0.05, p < 0.01). 
Statistical differences between migration rates for MSC alone and MSC-EC groups were 
determined using a two sample t-test (n>26, p<0.05). A circular statistics toolbox designed for 
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MATLAB was used to compare the average angle differences between the cell data and models 
(n=2,500)
118
. The Watson-Williams two-sample test (circular analog to the Student’s t-test) was 
used to compare the groups, with the angle binning of <10 degrees. This test assumes an 
appropriate von Mises distribution or circular analog of the normal distribution
118. With α = 0.05, 
a final p value was <0.01. Normality testing using the Kuiper test (circular invariant analog to 




Fabrication of Hydrogel Shapes and Templates 
Cells and cytokines were encapsulated in a GelMA, a naturally occurring peptide based 
hydrogel, that was fabricated using elastomeric poly(dimethylsiloxane) (PDMS) molds into a 
range of non-superimposable geometric shapes (Fig V-1, Fig V-2A-C). Each hydrogel shape 
was coded for the specific types and concentrations of encapsulated cells and cytokines, and was 
able to preserve cell viability and biological function over weeks of in vitro culture. Templates 
containing combinations of negative reliefs of shape geometries were designed to mimic 
different potential microenvironments (Figures 1d,e) and fabricated using methacrylated glass, 
which covalently crosslinked with the GelMA to form a substrate-attached hydrogel template 
(Fig V-2D,E). 
 
Specificity and Yield of Docking 
To maximize specificity of docking, different sets of canonical shapes were designed. 
Shapes sized at 60% of the surface area of their congruent well sorted with poor specificity, such 
that only 55% docked into their correct wells (Fig V-2I). When the shapes were sized to 85% of 
the surface area of their congruent wells, the specificity increased to 90% (Fig V-2J). The 
specificity remained unchanged over sequential rounds of shaking, confirming geometric 
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exclusion as the primary determinant of specificity. Shapes correctly sorted with a yield of ~20% 
in the first cycle, and an additional 10% in each subsequent cycle, to a maximum yield of 85%, a 
limit imposed by the maximum specificity. The yields and specificities of iterative sedimentation 
surpass those achieved with any previous technique. The change in hydrogel composition (% 
GelMA) had significant effect on mechanical properties of the hydrogel without affecting the 
sorting specificity or yield (Fig V-3). After sorting, another layer of GelMA was applied to 
permanently lock the sorted shapes into a cell microenvironment composed of a homogenous 
biocompatible hydrogel matrix. 
 
 
Figure V-1. A library of hydrogel shapes. Bright field images of 36 additional shapes are 
shown to demonstrate potential geometries and thus species that can be patterned. The English 
alphabet was chosen as a simple and easily recognizable set of distinct and mutually exclusive 
shape geometries. These additional shapes were designed to maintain mutual exclusivity with all 
other shapes. If more than 36 species need to be patterned, many other shape geometries can be 




Figure V-2. Engineering of geometrically defined cellular microenvironments by docking 
shape-coded hydrogels into hydrogel templates. (a) Schematic of micromolding approach to 
fabrication of gelatin methacrylate (GelMA) hydrogel. (b-e) Bright field microscopy images of 
(b,c) GelMA shapes and (d,e) GelMA templates. (f) Hydrogel shape docking into congruent 
template wells. (g,h) Merged fluorescent images of (g) free-floating hydrogel shapes before 
sorting, and (h) shapes within congruent wells after sorting. (i,j) Specificity of shape sorting as a 
function of shape geometry, the number of sorting cycles (1-10) and the ratio of the surface areas 
of the hydrogel and congruent well: (i) 60 % and (j) 85%. (k) Yield of sorting (the percentage of 
wells correctly filled), as a function of rounds of shaking for three shape geometries. Scale bars 
represent 300 µm. Data are shown as Average ± SD (n=20). 
 
Molecular Diffusion from Hydrogel Shapes 
The ability to encapsulate cytokines within GelMA, along with the precision of the 
sorting technique, provided a method to generate unique spatial gradients. Fluorescently tagged 
dextran or bovine serum albumin (BSA), surrogates for cytokines of large molecular size, were 
encapsulated into circular and rectangular shapes, docked to form specific patterns, and were 
allowed to outwardly diffuse. Over the course of 100 minutes, red fluorescent dextran emanated 
from the circle and green fluorescent dextran emanated from the rectangle, providing a spatial 
gradient field over the millimeter size scale (Fig V-4A – VI-4D). The evolution of the cytokine 
gradient demonstrated that the cytokine concentration changed with time in a predictable manner 
(Fig V-4E). Hydrogel composition modulated the diffusivity, with faster transport rates of 
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encapsulated bovine serum albumin measured for hydrogels made with a lower percentage of 
GelMA (Fig V-5). 
 
 
Figure V-3. Effect of different percent gelatin methacrylate on mechanical properties and 
sorting. (a) and (b) Mechanical testing of gelatin-methacrylate hydrogels. (a) Elastic and (b) 
equilibrium modulus of 5, 10, 15, and 20 w/v% gelatin methacrylate (n=4). The elastic modulus 
ranged from 0.5 kPa to 53 kPa, and the equilibrium modulus ranged from 1.3 kPa to 63 kPa. 
Both fit a power law with R2 values of 0.9999 and 0.9894. (c) and (d) Sorting specificity and 
efficiency for different shapes and gel percentages. The same sorting assays as in Figure 1 were 
performed using 10 and 20% w/v GelMA. (c) After five rounds of sorting, both 10 and 20% gels, 
and circles and rectangles sorted with approximately 80% specificity. Specificity was defined as 
the number of correctly docked shapes divided by the total number of docked shapes. Error bars 
represent standard deviation from the mean. Two-way ANOVA comparing different gel 
percentages and different shape geometries yielded no significant differences between groups 
(n=3, p>0.05). (d) Sorting yield, the percentage of total wells in the pattern filled with congruent 
shapes, were plotted as a function of rounds of shaking for the four different conditions. Error 
bars represent the standard deviation from the mean. Two-way ANOVA comparing different gel 
percentages and different shape geometries at each round of shaking yielded no significant 
differences between groups (n=3, p>0.05). 
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Figure V-4. Regulation of cellular function by the geometry and organization of hydrogel 
shapes. (a-d) Time lapse images of sorted circles and rectangles dosed with 100 µg/mL Texas-
Red tagged 10 kDa dextran and 100 µg/mL Alexa-488 tagged 10 kDa dextran respectively. Scale 
bars: 600 µm. (e) Fluorescent intensities were obtained starting from the circle edge and to a 
distance of 2 mm from the circle edge for five different time points. Intensities were normalized 
to the maximum intensity across all time points. Relative fluorescent intensity of Texas-Red 
tagged 10 kDa dextran was plotted as a function of distance from the circle at the five different 
time points. (f,g) Neonatal cardiomyocytes encapsulated within GelMA rectangles after 4 days of 
cultivation. Fluorescent Live/Dead staining (left) is shown along with the associated bright field 
images (right), for the shape geometries with (f) 1:3 aspect ratio (100 x 300 µm) and (g) 1:10 
aspect ratio (100 x 1,000 µm); the length of dotted line to solid line shows average deformation 
of rectangles (n=15) (h) Contraction frequency (Hz) for 1:3 and 1:10 aspect ratio rectangles, 
shown as average ± SD (n=27, α = 0.05, *p < 0.01). (i) Contraction deformation (percentage of 
the total length) for hydrogel rectangles with a 1:3 and 1:10 aspect ratio, shown as average ± SD 
(n=50, α = 0.05, p < 0.01).  (j,l) Human mesenchymal stem cells (MSC) within GelMA hydrogel 
after 14 days of cultivation, cultured alone (j) or in co-culture with endothelial cells (EC) (l). 
(k,m) Magnification of regions outlined by the white rectangles in (j,l) Scale bars: 300 µm. (n) 
Confocal microscopy of actin (green) and DAPI (blue) staining of MSC growth towards EC after 




Fig V-5. Diffusion of BSA from gelatin-methacrylate hydrogels. Circles fabricated with 10% 
w/v GelMA and 20% w/v GelMA were dosed with Texas-Red tagged BSA and were sorted in 
10% w/v GelMA and 20% w/v GelMA respectively. Time lapse images of sorted circles dosed 
with Texas-Red tagged BSA were taken at 10 minute intervals for 100 minutes. Relative 
fluorescence intensity was plotted as a function of distance from the circle edge for 5 time points. 
(a) represents a plot for 10% w/v GelMA while (b) represents 20% w/v BSA. (c) For each time 
point, the distance to 50% intensity was determined and plotted as a function of time. These fit a 
linear curve with R2 of 0.9362 and 0.9918. The higher slope for the 10% w/v GelMA diffusion 
suggests a higher rate of diffusion. 
 
Engineering Cell Behavior Using Hydrogel Shapes 
We demonstrated that hydrogel shapes can be used to form biomimetic cell environments 
to modulate the function of encapsulated cells. As an example, neonatal rat cardiomyocytes were 
encapsulated within rectangular hydrogels of two width/length aspect ratios: 1:3 and 1:10. After 
seven days of culture, all shapes exhibited spontaneous macroscopic beating, with high fractions 
of viable cells (>98%, Fig V-4F,G) and remarkable differences in contractile cell function. 1:3 
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rectangles contracted at a significantly higher frequency and to only ~12% of their length, 
whereas the 1:10 rectangles contracted more slowly and to ~36% of their total length. These data 
suggest differential phenotypic maturation of cardiac subunits by simple changes in hydrogel 




Figure V-6. Timeline of MSC migration in shape-coded templates, cultured alone and with 
ECs. (a) Bright field images of the MSC monoculture after 14 days, where encapsulated MSCs 
migrated from the circular hydrogel through the GelMA matrix. (b) Bright field images of the 
MSC-EC co-culture, showing the progression of encapsulated MSC cell migration over 14 days 
from the circular hydrogel to the endothelial cell laden rectangular hydrogels. Two 
magnifications are shown for both sets of images. Scale bars: 300 µm. 
 
Patterning Mesenchymal Stem Cell Migration 
The hydrogel sorting platform was then employed to control the co-culture of human 
mesenchymal stem cells (MSCs) and human endothelial cells (ECs). MSCs were encapsulated in 
circular hydrogels, sorted into centrally positioned circular wells, and allowed to migrate out of 
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the hydrogel toward the surrounding rectangles containing either acellular or EC-laden hydrogels 
(Fig V-4J-M, Fig V-6). Images in both groups were taken at the same timepoints, with the only 
variable being the presence of ECs. MSCs by themselves migrated out in a constant symmetric, 
radial fashion, however MSCs cultured with EC containing hydrogels initially migrated radially,  
curved their trajectories over time, creating long, arcing sprouts homing toward ECs.  Confocal 
microscopy of actin (Fig V-N) provided a closer view of the cytoskeletal architecture of the 
migratory MSC sprouts. This visually striking, spatially dependent influence on MSC growth 
suggested a gradient-based communication between the two cell types. 
 
Finite Element Model of Cell Migration 
To explore gradient effects between the ECs and MSCs, a 3D finite-element model was 
built using the two hydrogel shape types as gradient sources (Fig V-7A). The model accounted 
for two driving forces: (1) repulsive homotypic interaction between MSCs dictating cell 
migration from a region of high to low cell density (MSC-MSC repulsion), and (2) the 
chemotactic gradient of EC secreted factors dictating MSC migration from a region of low to 
high cytokine concentration (MSC-EC attraction). The MSC-only system was driven solely by 
the repulsive cell gradient, while the co-culture system combined the two driving forces to form 
a gradient field akin to a dipole electric field. The gradient field model was used to check the 
relative independence of specific shape geometry on the subsequent formation of the gradient 
field. Different shapes - rectangles, circles and squares, all formed similar gradient fields when 
positioned equally, validating that the mutual exclusivity of shape geometry did not necessitate 
variable gradient formation. (Fig V-8A-C) Changing individual shape geometry had only a small 
effect compared to changing spatial position of wells in the hydrogel template, which caused 
grossly different gradient patterns (Fig V-8D-F). When biologically assessed, cell migration in 





Figure V-7. Modeling of cell migration. (a) Schematic diagram of MSC migration in response 
to concentration gradients generated by ECs. (b,c) Cell vectors were generated from Day 14 
phase contrast cell images using image processing techniques. Average migration rates were 
measured using the vectors generated for each group. (d,e) Representative examples of overlays 
of processed cell vectors and COMSOL modeled vector fields for the two culture conditions: (d) 
MSC only and (e) MSC-EC co-culture. Insets: magnifications of the outlined regions to illustrate 
correlation between the two vector fields. The average angle difference between the measured 
cell vector and model prediction was calculated for the matched and unmatched models. (f,g) 
Radial distribution of the angles of cell trajectories, with the bin set to 10o. (h) Heat map of angle 
magnitudes between standard radial coordinates and cell data. (i) Heat map of angle differences 
between co-cultured cells and the corresponding matched or mismatched model. The color-coded 
bar shows the angle correlation for the heat map. 
 
 
Figure V-8. Finite element modeling of concentration gradients. Colored arrows represent the 
relative contribution of either of the two driving forces for the resultant gradient vector, where 
red represents MSC outward migration as the primary driving force and blue represents EC 
attraction as the primary driving force. (a-c) Independence of the concentration gradient field 
from shape geometry. Concentration gradient profiles are shown as arrow plot with three 
different shape geometries for the exterior shape: (a) Rectangles (b) Squares and (c) Circles. The 
same spatial arrangement as found in Figure 2 and 3 was used to position the two different shape 
types in each simulation. (d-f) Dependence of the concentration gradient field on shape 
arrangement. Concentration gradient profiles are shown as arrow plot with three different 
arrangements of shapes. (d) Reversed shape pattern from the rectangle and circle placement 
found in Figure 3, with a rectangle in the center with surrounding circles. (e) A linear gradient 
field can be created by arranging the shapes in rows. (f) Repeating the pattern found in Figure 3 




Figure V-10. Timeline of MSC migration in shape-coded templates, cultured with ECs. 
Bright field images of MSC-EC co-culture at 4, 10, and 14 days, showing the progression of 
MSC migration over time. MSCs were encapsulated in circles while ECs were encapsulated in 
rectangles. Scale bars: 600 µm. 
 
Cell Migration Vectors 
To validate the accuracy of the gradient model of cell migration behavior, cell trajectories 
were quantified in the time-lapse images by generating cell-associated vectors using a 
MATLAB-based image segmentation algorithm. Contrast thresholding, image smoothing, Sobel 
edge detection function, and a watershed transformation were implemented to create segmented 
image areas for each cell (Fig V-11). Ellipses were inscribed within segmented areas, and the 
resultant long axis vector was used to represent the cell (Fig V-7B-C). The vectors formed a 
comprehensive dataset (corresponding to ~2,500 cells), to allow quantitative comparisons to be 
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made for cell migratory speed, angular distribution, and correlation of cell migration to the 
developed gradient model. Using the vector dataset, an average rate of MSC migration was 
calculated in the presence or absence of ECs. The MSCs alone migrated with an average speed 
of 25.9 µm per day, but when in the presence of ECs, they migrated 36.1 µm per day (a 40% 
increase, p = 4.2×10
-5
). The angular distributions of cells were examined using histograms of the 
cell angles relative to the right horizontal axis. (Fig V-7F,G). MSCs cultured alone exhibited 
uniform distributions, while MSCs co-cultured with ECs clustered at angles correlating to the 
locations of ECs. 
 
 
Fig V-11. Schematic of image processing. (a) Experimental images of migrating cells were 
processed using an image-processing algorithm in MATLAB to recognize each cell as a vector 
for quantification. (b) Once each image was transformed into a vector of cell data, multiple 
images were combined using the same relative spatial landmarks. (c) Finally, the vectors were 
compared to those generated from the finite element modeling. 
 
Correlation of Cell Migration to Finite Element Model 
The measured directions of cell migration were compared to model predictions by 
superimposing cell vector data onto the model vector fields. Overall, the migrating cells followed 
the gradient field lines (Fig V-7D,E). Along radial diagonal lines between rectangles in the co-
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culture model, the migratory deviations reflected ambiguous cell responses to competing 
gradients (equal attraction to both rectangles) (Fig V-7D,E). 
For quantitative comparison, the angles between cell data vectors and model vectors were 
measured. The angle between the cell data vector and the finite-element model vector ranged 
from 0° to 90°, 0 corresponding to perfect agreement between the data and the model (Fig V-
7D,E Inserts). Comparison of the MSC only data with the single gradient model resulted in an 
average angle deviation of 21.1°, substantiating that ~20° deviation is intrinsic to MSC 
migration. Interestingly, the average angle was 22° and 29° when comparing the co-culture cell 
data to the co-culture model and radial model respectively. A statistically significant decrease 
(by ~7°, p = 2.23×10
-7
) of the average angle validates that two simple driving forces can 
establish a gradient model accounting for the interactions between MSCs and ECs. 
To spatially resolve where the MSCs deviated from the radial model and migrated 
towards the endothelial cells, heat maps of cell direction identified the locations where the cells 
followed the co-culture model over the radial model (Fig V-7I). The red areas of the heat map 
indicate the specific regions where the MSCs responded to the paracrine signaling effects of 
endothelial cells by changing course from a radial migratory pattern, which occurred close to the 
EC containing rectangles. By comparison, the heat map of the angle magnitudes (Fig V-7I) for 
the MSC only data compared to the single gradient model showed no spatial localization. 
 
DISCUSSION 
This simple assembly technique solves some of the problems of fidelity and stepwise 
construction of cellular microenvironments, by virtue of precision, versatility and scalability. 
Precision was achieved using mutual geometric exclusion, where shape coded hydrogels could 
be uniquely tuned to ensure high specificity of spatial docking within the hydrogel template (Fig 
V-2). Versatility was achieved using combinatorial patterning of multiple shape geometries with 
customizable amounts of encapsulated cells, or cytokines. Additionally, the hydrogel material, 
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GelMA, is highly biocompatible, supports physiologic cell functions, and has tunable stiffness 
and diffusivity. Efficiency and scalability were achieved through the use of an iterative docking-
resuspension protocol (Fig V-2). Shear protection allowed for rapid conjugate-well filling due to 
accumulation of successfully docked shapes in the final assembly. Since each docking event was 
independent, organization occurred in parallel, solving scalability problems, as the building 
blocks were placed not sequentially, but simultaneously. Thus, both micro-sized cell niches and 
large tissue constructs can now be assembled over short time periods. 
Cell migration was particularly apt to study diffusive cell-cell communication during 
vasculogenic network formation, due to the visible spatial organization of vascular cells along 
the cytokine gradient fields. (Fig V-4, VI-7). Despite potentially complicated signaling networks 
between MSCs and ECs, the pattern formation was predictable using only two driving forces - 
MSC-MSC repulsion, and MSC-EC attraction. The mechanism of outward cell migration is not 
fully understood
119, 120
, and has been described as a general diffusive process
121, 122
. There is 
evidence that cytokines, specifically PDGF-BB, are involved in the recruitment of MSC to the 
EC microenvironments
74, 123
, and this may be one of the major constituents of the overall 
chemotactic force of the ECs to the MSCs, though multiple factors are at work. Combined with 
the image processing algorithm to build a large and reproducible cell vector dataset, the 
chemotactic effect of EC’s was quantified resulting in an estimate for the increased rate of 
migration (~40%) that EC’s can attract MSC’s within a micro-scale 3D hydrogel.  
We present a universal fabrication platform for precisely generating complex 3D cell-
microenvironments over multiple size scales, by patterning any number of encapsulated cells and 
cytokines, in any configuration, simultaneously. The characterization of paracrine cell-cell 
interactions was done using advanced image processing, finite element modeling and complex 
3D cell patterning. Two model growth patterns for MSC migration provided the basis for 
mathematical models defining spatial maps of diffusive cell communication. Due to the 
pervasive effect of the cell microenvironment on cell function, we envision that this method of 
subunit-based microenvironmental assembly will be used to explore numerous processes, such as 
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Aim 4 :Tissue Function: Tubular Silk Scaffolds for Small Diameter Vascular 
Grafts 
ABSTRACT 
Vascular surgeries such as coronary artery bypass require small diameter vascular grafts 
with properties that are not available at this time. Approaches using synthetic biomaterials have 
been not completely successful in producing non-thrombogenic grafts with inner diameters less 
than 6 mm, and there is a need for new biomaterials and graft designs. We propose silk fibroin as 
a microvascular graft material and describe tubular silk scaffolds that demonstrate improved 
properties over existing vascular graft materials. Silk tubes produced using an aqueous gel 
spinning technique were first assessed in vitro in terms of thrombogenicity (thrombin and 
fibrinogen adsorption, platelet adhesion) and vascular cell responses (endothelial and smooth 
muscle cell attachment and proliferation) in comparison with polytetrafluoroethylene (PTFE), a 
synthetic material most frequently used for vascular grafts. Silk tubes were then implanted into 
the abdominal aortas of Sprague-Dawley rats. At time points of 2 weeks and 4 weeks post 
implantation, tissue outcomes were assessed through gross observation (acute thrombosis, 
patency) and histological staining (H&E, Factor VIII, smooth muscle actin). Over the 4-week 
time period, we observed graft patency and endothelial cell lining of the lumen surfaces. These 
results demonstrate the feasibility of using silk fibroin as a vascular graft material and some 
advantages of silk tubes over the currently used synthetic grafts. 
 
INTRODUCTION 
With the constant increase in the incidence of atherosclerosis, there is a need for small 
vascular grafts (<6 mm inner diameter, ID) for vascular surgeries such as coronary or femoral 
artery bypass. Clinically, the current “gold standard” is autologous grafting, where the saphenous 
vein or an internal mammary artery is used to bypass the diseased vessel
124
. Unfortunately, in 
 98 
patients who have had previous bypass surgeries or vascular disease, the veins and arteries are 
often unsuitable for harvest
125
. In addition, the need to generate a second surgical site can lead to 
greater risk of infection, swelling and discomfort. Thus, there is a long-standing need to develop 
a functional alternative to autologous grafting. 
Currently available synthetic grafts, such as expanded polytetrafluoroethylene (ePTFE, 
Teflon®) and polyethylene terephthalate (PET, Dacron®), are successful at the macrovascular 
level, but fail at smaller diameters (<6 mm ID) due to thrombosis and/or compliance 
mismatches
126-128
. Because this is the actual scale of interest for coronary and femoral artery 
bypass procedures, numerous chemical and physical modification techniques have been 
developed and applied to synthetic grafts to tailor the materials with desired bioactivity and 
biocompatibility.  These techniques include chemical grafting of functional groups, plasma 
surface modifications, and physical adsorption of coatings, typically using an anticoagulant such 
as heparin as the bioactive agent
129-131
. These methods, however, are limited due to complexity 
of processing, loss of activity of biomolecules delivered within or on these coatings, and lack of 
control of the spatial orientation of the material.  In addition, most of these systems are non-
degradable, prohibiting full restoration of original tissue structure and function over time. 
The need for new biomaterials and approaches to generate functional small diameter 
vascular grafts with capacity for remodeling remains acute. The design criteria are stringent, in 
particular with respect to mechanical competence, non-thrombogenicity, and ability to remodel 
over time into a fully functional blood vessel. Additional requirements include biocompatibility, 
degradation, compliance, precise geometry, suturability, and non-immunogenicity, and easy 
translation into pre/clinical studies.  To address this challenge, we propose to use a natural 
biopolymer, silk fibroin, which offers robust and tailorable mechanical properties along with 
biocompatibility, slow degradation in vivo, and versatile processing options to permit the 
formation of small diameter tubular systems
128, 132
. 
To accomplish this goal, aqueous silk solutions were spun using a custom-designed, 
aqueous gel spinning technique capable of producing small diameter tubular conduits with fine 
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control over tube properties (mechanics, lifetime, functional features)
132
.  In this work, the focus 
was placed on using lyophilized silk tubular grafts to address issues of compliance as well as 
vascular cell migration and proliferation.  Silk material was evaluated in terms of mechanical 
strength, thrombogenic potential, and vascular cell response in comparison to other materials, 
specifically PTFE.  These materials were assessed for thrombogenic protein (thrombin, 
fibrinogen) adsorption, platelet adhesion, as well as endothelial and smooth muscle cell 
attachment and proliferation.  In terms of in vivo work, silk grafts were implanted into the 
abdominal aorta of Sprague-Dawley rats by end-to-end anastomosis and evaluated first for signs 
of acute thrombosis, then were harvested at two and four week time points to evaluate patency as 
well as the presence of smooth muscle cell migration/proliferation and a confluent endothelium.  
This work suggests that silk may be a suitable material for small diameter vascular grafts, 
addressing current issues of thrombosis and compliance through control of material deposition, 
processing, and function. 
 
MATERIALS AND METHODS 
Silk tube manufacture 
Silk fibroin aqueous solutions were obtained from Bombyx mori silkworm cocoons using 
previously described procedures
132
.  Briefly, the silkworm cocoons (supplied by Tajima Shoji 
Co., LTD., Yokohama, Japan) were extracted in 0.02 M sodium carbonate solution, rinsed in 
distilled water, dissolved in 9.3 M lithium bromide, and dialyzed against distilled water using a 
Slide-a-Lyzer dialysis cassette (molecular weight cutoff MWCO, 3,500, Pierce, Rockford, IL) 
for 48 hours.  The resulting 6-8% (w/v) fibroin solution was then concentrated by dialyzing 
against 10 wt% poly(ethylene glycol) (PEG) to produce a 25-35% (w/v) silk fibroin aqueous 
solution. 
Tubes were prepared by using a previously described gel spinning approach
132
.  Briefly, a 
concentrated silk fibroin solution (~25-35% (w/v)) was driven through a 27 or 30 gauge needle 
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onto a rotating and axially reciprocating mandrel.  After evenly coating the mandrel with the 
concentrated silk fibroin using the desired winding pattern, the tubes were frozen and 
lyophilized.  After brief treatment with methanol, the silk-coated mandrel was placed in a 
surfactant solution to remove the silk tube from the Teflon-coated stainless steel rod. 
 
Structural testing of graft materials 
Tensile tests were performed on hydrated silk tubes and ePTFE grafts (ID=1.5±0.05 mm, 
wall=0.1±0.03 mm, Zeus, Orangeburg, SC) as previously described
132
.  Briefly, an Instron 3366 
testing frame with a 10N or 100N capacity load cell and Biopuls pneumatic clamps was used to 
test the sample tubes (N=3-5).  Tubes were measured using a caliper (20-30 mm in length) and 
hydrated in 0.1M phosphate buffered saline (PBS) for approximately 30 minutes before 
clamping and submerging in a temperature-controlled (37 ± 0.3oC) bath of PBS for at least 5 
minutes prior to testing.  A crosshead displacement rate of 5 mm/min was used and tensile stress 
vs. strain was plotted.  The linear elastic modulus was calculated using a least-squares fitting 
between 0.1N (silk) or 1N (ePTFE) load and 2.5% strain past that point.  The yield strength was 
determined by offsetting this least-squares line by 2% (silk) or 0.2% (ePTFE) strain and marking 
the data intercept.  Ultimate tensile strength was the highest stress value attained during the test 
and the elongation to failure was the last data point before a >10% decrease in the load. 
 
Protein Adsorption to silk and PTFE films 
Protein adsorption to silk films was compared to PTFE using thrombin and fibrinogen, 
proteins of the common thrombotic pathway.  Silk and PTFE films were deposited into wells of 
Maxisorp plates (Nunc Brand, Fisher Scientific, Rochester, NY) after blocking the wells with 1% 
BSA in PBS-Tween solution (0.05% (v/v) Tween 20 in PBS).  Silk films were made by pipetting 
50 µL of 6-8% silk solution into each well, drying overnight, and treating with 70% methanol 
while PTFE films were made by using a biopsy punch to create 6 mm diameter samples of PTFE 
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film (0.05 mm thickness, McMaster-Carr, Robbinsville, NJ) and holding the films in place by 
using a small amount of medical device adhesive (Loctite® 4013). 
In order to quantify protein adsorption to silk and PTFE films, each protein was 
biotinylated using an EZ-Link NHS-Chromogenic Biotinylation Kit (Pierce, Rockford, IL).  An 
amine-reactive NHS ester is coupled to a chromogenic group, a polyethylene glycol (PEG) 
spacer, and a biotin group.  This reagent was used to react to the primary amino groups on the 
proteins of interest, forming stable amide bonds and allowing for quantification of biotin 
incorporation through the use of the incorporated chromophore.  Varying concentrations of these 
biotinylated proteins (0 to 5 µg/mL) were, in turn, incubated overnight at 4oC on the silk and 
PTFE films, as well as on uncoated Maxisorp plates (100 µL/well), before evaluating adsorption 
using an enzyme-linked immunosorbent assay (ELISA)-based technique similar to those 
described previously
133
. Briefly, after incubation, wells were washed with PBS-Tween and 
blocked with 1% BSA in PBS-Tween to inhibit non-specific binding.  After incubation, the plate 
was washed again with PBS-Tween before adding horseradish peroxidase (HRP)-conjugated 
streptavidin.  After an additional incubation and washing step, TMB was added to each well, 
incubated until sufficient color development, stopped by addition of 2N sulfuric acid, and 
transferred to a fresh plate for reading absorbance at 450 nm using a microplate reader.  
Absorbance values for the different concentrations of biotinylated proteins on the silk and PTFE 
films were compared to the absorbance values for different concentrations on a standard curve on 
the uncoated Maxisorp plate. 
 
Cell culture 
Human coronary artery smooth muscle cells (HCASMCs), human umbilical vein 
endothelial cells (HUVECs), and a GFP-expressing line of HUVECs (GFP-HUVECs) were used 
to evaluate silk as a graft material
134
. Prior to seeding, they were cultured according to previously 
reported protocols where the HUVEC cell lines were grown in optimized growth media EGM-2 
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(Lonza, Walkersville, MD) supplemented with 100 U/mL penicillin, 1000 U/mL streptomycin, 
and 0.2% fungizone antimycotic (GIBCO, Carlsbad, CA), and HCASMCs were cultured in 
smooth muscle cell medium (SMCM) with 2% fetal bovine serum (FBS), 1% smooth muscle cell 
growth supplement, and 1% penicillin/streptomycin solution (ScienCell Research Laboratories, 
Carlsbad, CA).  In some cases, prior to cell seeding, HCASMCs were stained using a red 
CellTracker dye at a concentration of 10 µM according to company protocols (Invitrogen, 
Carlsbad, CA). 
 
Graft material characterization – vascular cell attachment & proliferation, platelet 
adhesion 
The cellular components of thrombosis, vascular cell attachment and proliferation as well 
as platelet adhesion, were assessed on films as well.  Initial cell adhesion was monitored 
fluorescently using the GFP-transduced HUVECs or CellTracker dye for HCASMCs, counting 
the number of cells using ImageJ software.  To assess cellular proliferation, HCASMCs and 
HUVECs were seeded onto the silk and PTFE films in a 24-well plate (2 x 104 cells/well), with 
changes in DNA content were monitored every 3-4 days over the course of two weeks using a 
PicoGreen dsDNA assay (Invitrogen).  Growth curves of the cells on silk and PTFE were 
compared with that of cells on TCP as a positive control. 
To assess hemocompatibilty, platelets were obtained from platelet rich plasma (Research 
Blood Components), diluted in PBS to 1x10
7
 cells/mL, and incubated on films for 30 minutes 
before washing, fixing, and staining using CD61+ antibody staining.  Briefly, after incubation, 
the films were washed 3 times with PBS to remove non-adherent platelets and fixed in 4% 
formalin for 20 minutes.  After another series PBS washes, adherent platelets were stained using 
monoclonal antibody CD61 (Beckman Coulter, Fullerton, CA) as the primary antibody and 
Alexa Fluor 488 chicken anti-mouse IgG as the secondary antibody (Invitrogen).  Platelets were 




Imaging of silk tubes and films – SEM and fluorescent microscopy 
Scanning electron microscopy (SEM) and fluorescence microscopy were used to 
visualize the surface morphology of the silk tubes or silk films and evaluate cell and platelet 
attachment, respectively.  Tube samples for SEM were sputter coated with gold using a Polaron 
SC502 Sputter Coater (Fisons, VG Microtech, East Sussex, England) and imaged using a JEOL 
JSM-840 Scanning Microscope (JEOL Ltd., Tokyo, Japan).  Fluorescence images of the silk 
films were acquired using a Leica DMIRE2 confocal microscope with a TCS SP2 scanner (Leica 
Microsystems, Mannheim/Wetzlar, Germany). 
 
Graft implantation 
Silk tubes were implanted in the abdominal aorta of Sprague-Dawley rats via an end-to-
end anastomosis model
135, 136
. All procedures were performed under the protocol number 
AAAA6464-300, approved by the Columbia University Institutional Animal Care and Use 
Committee (IACUC).  Prior to surgery, the silk tubes were adjusted to meet the anatomical 
requirements of the rats (1.0-1.5 mm inner diameter x 20 mm in length) before surgery and the 
rats were heparinized to help prevent thrombosis.  The surgical model involved a midline 
laparotomy and subsequent exposure of the infrarenal abdominal aorta.  Microclamps were used 
to halt blood flow, and the aorta transected and washed with saline.  The silk graft was then 
interposed after necessary trimming of the adventitia and length of the native aorta, and secured 
by 8-0 monofilament polypropylene sutures (total of 12).  Target ischemia was within 30-60 
minutes and graft patency was acutely assessed using a blanching flow-no flow technique before 
closing the animal.  The rats were sacrificed at two- and four-week time points and the grafts 
were evaluated histologically, staining segments of the grafts using hematoxylin and eosin 
(H&E), Masson’s trichrome for collagen, smooth-muscle actin, and factor VIII for endothelium. 
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Structural comparison of native tissue with graft materials 
To compare the structural properties of replacement tubes (silk and PTFE) to the native 
tissue site, the sections of transected rat aortas were looped several times by polypropylene 
sutures and left in PBS. Samples were anchored to steel hooks via sutures, and submerged in 
temperature-controlled Biopuls bath (37 ± .3°C) filled with .1M PBS (Sigma) for 5 minutes prior 
to testing. After 5 minutes was complete, the sample was straightened by eye and the load was 
tared. During the test, a displacement control mode was used, with a crosshead displacement rate 
of 5 mm•min-1. The initial gage length was measured as the suture-suture distance and the 
original cross sectional area determined by histology (H&E staining). The gage length was 
corrected in post-processing by normalizing to a .05N preload for each sample, and this load was 
thereby extracted from the data set (.05N = 2-3% of the maximum breaking load seen during 
testing). The tensile stress (σ) and strain (ε) were graphed and ultimate tensile strength 
determined from the processed data, defined as the highest stress value attained during the test. 
This value is equivalent to the suture pull-out retention capacity of the tissue. The elastic 
modulus was established by curve-fitting the stress-strain data to an exponential stiffening 
constitutive model using MATLAB software
137, 138
.  
The constitutive equation has the form σ=A[exp(Bε)-1] and has been used previously to 
model cartilage, meniscus, and ligament tissues (other collagen-fiber reinforced tissues). 
Parameters A and B were found using a least-squares minimization technique. The derivative of 
this equation is E=Bε + C where C is the product of AB and E is the tangent elastic modulus. 
The elastic modulus was calculated at a stress value .2MPa (using the corresponding strain 




Silk tube manufacture 
A silk gel spinning approach was used to form tailored silk tubes with unlimited control 
of winding parameters and post-winding processing techniques (Fig VI-1). This was achieved by 
depositing silk onto a reciprocating rotating mandrel, controlling the rate of rotation and axial 
slew, and subjecting the tubes to methanol treatment, air-drying, or lyophilization before removal 
from the mandrel (Fig VI-1A-C).  In this study, silk tubes were produced using a simple 
wrapping pattern, lyophilized post-winding, and chosen due to their porous, lamellar-like 
structure when compared to the other silk tube formulations (Fig VI-1D-G).  The lyophilized 
tubes display an increased surface roughness and porosity, allowing for potential cell ingrowth in 
vivo and are also generally more flexible, a critical parameter when considering a vascular graft. 
The all-aqueous nature of the gel spinning process allows for specific thrombotic target 
factors (e.g., paclitaxel, heparin, warfarin, aspirin, or clopidogrel) to be incorporated directly into 
the tubes to regulate cell and protein response
139, 140
. Previous work in our lab has focused on the 
incorporation of paclitaxel, a vascular smooth muscle inhibitor commonly found in drug-loaded 
stents
141, 142
 and shown in previous studies using silk to inhibit smooth muscle cell 
proliferation
132
. By incorporating different doses (10 µg/mL to 1 mg/mL) of paclitaxel into the 
tubes during the silk spinning process, smooth muscle cell proliferation may be regulated as 






Figure VI-1. Silk fibroin vascular grafts. (a) schematics of gel spinning process used to 
produce silk tubes where a concentrated silk solution is expelled through a small gauge needle 
and wound onto a rotating reciprocating mandrel. (B) Image of the gel spinning apparatus; (c) 
images of grafts compared in this study, silk and epTFe; seM images of silk tubes both 
longitudinally (D and F) and in cross-section (E and G) 
Mechanical evaluation of vascular graft materials 
Structural properties of silk, ePTFE tubes, and native rat abdominal aortas were evaluated 
using tensile testing, comparing values of elastic modulus and ultimate tensile strength between 
the two materials and the native tissue. In general, we observed a major qualitative difference in 
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their overall stress-strain behavior. While the replacement materials (PTFE and silk) had a linear-
elastic behavior in the low-strain regime, leading to a large zone of plastic deformation, the 
stress-strain response of human and rat native vascular systems contained a large “toe region” 
directly preceding the more linear behavior (from where the elastic modulus was extracted). This 
toe region can be observed in structural longitudinal tests of the entire vessel (herein) or when 
sections of the side wall are evaluated separately
143
. This toe region is due to the eventual 
straightening and alignment of elastin fibers, and acts as a means of regulating compliance of the 
vessel during normal systolic and diastolic pressures. As shown in Table VII-1, both mechanical 
parameters are orders of magnitude higher for the ePTFE tubes when compared to the silk grafts, 
indicating that the ePTFE is a stronger, stiffer material. While these properties are suitable for 
treatment of large diameter arteries where blood flow is higher and the resistance is low, this 
mismatch in mechanical strength between ePTFE and native vessels at smaller diameters lead to 
disappointing patency rates
144
. Conversely, silk tubes display mechanical properties that more 
closely match those of the rat aorta and human saphenous vein
145-147
, raising the possibility that 
by more closely matching the compliance properties of small diameter vessels, thrombogenicity 
could be reduced. Mechanical property matching was used as an a priori design evaluation tool 
given that compliance mismatch and differences in elasticity at points of anastomosis are 
suggested as primary causes of thrombosis. While design of a toe-region behavior was not 
prioritized, this feature could be accommodated by providing the tube with a further criss-
crossing fibrillar winding patterns typical of textile-based structures. Radial compliance and tube 
burst pressure may also be regulated through careful modifications to the silk tube making 
process. While these mechanical tests were not performed here due to the small diameters of the 
samples, previous work using electrospun or aqueous-dipped silk tubes have demonstrated 






Table VII-1. comparison of structural properties of native aorta and graft material 
 
Thrombogenic potential of silk and pTFE 
Evaluation of the thrombogenic potential of silk compared to other materials was 
performed by observing the amount of thrombin and fibrinogen adsorption to silk and PTFE and 
by comparing  platelet adhesion and spreading on silk as compared to PTFE, collagen, glass, and 
glass coated with bovine serum albumin (BSA) (Fig VI-2). For the adsorption of thrombin and 
fibrinogen, these proteins were chosen for their respective roles in the common thrombogenic 
pathway.  By evaluating their adsorption to silk and PTFE films as compared to controls, a sense 
of their relative thrombogenicity could be ascertained.  The proteins were biotinylated to 
quantitatively assess the amount of protein adsorbed to each surface and concentrations of each 
protein (0 to 5 µg/mL) were deposited onto the silk and PTFE films as well as Maxisorp plates as 
a control.  As shown in Fig VI-2A-B, there was a dose dependent response of the protein 
adsorbed by the films to the concentration of protein incubated on the films that held true for 
both the biotinylated thrombin and fibrinogen.  In addition, the amount of protein adsorbed onto 
the silk films was lower than that of the PTFE films for all cases, indicating that silk may be less 
thrombogenic in vivo as compared to the synthetic PTFE.  The mechanism of this adsorption 
may be due to hydrophobic interactions between the proteins and the films as contact angles of 








. This small increase in the hydrophobicity of the PTFE compared to the silk 
may account for the slight increase in protein adsorption, though it should be noted that both 
surfaces adsorb only small amounts of protein (less than 5 ng) compared to the amount of protein 
loaded (0.05 to 0.5 µg), indicating low thrombogenicity. 
Hemocompatibility of these materials was also assessed by platelet adhesion and 
spreading on silk and PTFE as compared to other control films and surfaces.  Platelet rich plasma 
was incubated on silk, PTFE, and collagen films with glass and glass coated with 0.5% BSA 
serving as the positive and negative controls, respectively
151
. As shown in Fig VI-2C-D, PTFE 
demonstrated the least amount of platelet adhesion, with silk and collagen films demonstrating 
higher numbers of adherent platelets.  Platelet adhesion to glass coated with BSA as compared to 
unmodified glass likewise demonstrated less adhesion for the former as opposed to the latter.  
Considering the morphology of the adherent platelets, however, a similar level of spreading is 
observed for platelets attached to silk and PTFE (Fig VI-2D). While they do not display the 
round morphology of platelets found on collagen or glass coated with BSA, they are far from the 
completely spread morphology of platelets adherent to unmodified glass, an indicator of platelet 
activation
152
. By demonstrating platelet morphology close to those found on surfaces known to 
not activate platelets (collagen, BSA-coated glass), silk and PTFE surfaces may be less 





Figure VI-2. characterization of thrombogenic potential of different materials. adsorption of 
biotinylated thrombotic pathway proteins thrombin (a) and fibrinogen (b) to silk fibroin and 
pTFe films. protein concentrations on each film ranged from 0 to 5 μg/mL and protein adsorption 
to the films was quantified using an ELISA technique. platelet adhesion after 30 minute 
incubation quantified in terms of platelets per square millimeter (c) with images of platelets 
adherent to the different materials (d). 
 
Characterization of vascular cell attachment & proliferation 
In order to assess the ability of silk tubes to be remodeled in vivo, the attachment and 
proliferation of both endothelial and smooth muscle cells was considered.  In particular, the 
ability of the cells to grow on silk films in vitro as compared to PTFE and/or collagen films as 
well as TCP provides a sense for whether these cells could migrate, adhere, and remodel these 
materials in vivo.  As shown in Fig VI-3A-B, cell attachment to silk films for both HUVECs and 
SMCs is higher than that of PTFE.  This suggests a higher likelihood of cell attachment and 
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potential for vascular remodeling.  In this case, PTFE serves largely as an inert material, with 
limited ability for cell integration.  Both the silk and PTFE films demonstrate a dramatic 
reduction in cell binding as compared to collagen films or TCP, perhaps providing an 
intermediate cell attachment as opposed to rampant cell attachment that can lead to hyperplasia 
and vessel occlusion in vivo.  This ability of cells to proliferate on these materials was assessed 
using a PicoGreen dsDNA assay, monitoring cell growth over a two week time period.  In this 
case, the rate of cell proliferation on the silk films was intermediate as compared to TCP and 
PTFE.  This implies that vascular cells (HUVECs, SMCs) may proliferate on silk and remodel 
the vessel in a way not observed on standard PTFE (Fig VI-3C-D).  By actively proliferating, the 
cells may remodel the silk graft at a rate equal to the rate of degradation, ultimately resulting in a 
fully remodeled graft with the same properties as the native vessel.  This may be further 
controlled by varying silk processing conditions, as we recently reported that vascular cell 
proliferation may be mediated by loading with therapeutic compounds such as paclitaxel, 
heparin, and/or clopidogrel 
 
In vivo evaluation of silk tubes 
Using an abdominal aorta implantation model in rats, silk tubes were assessed in vivo for 
potential as a vascular graft material.  The rats exhibited no signs of acute thrombosis (within 24 
hours), and were monitored throughout the study for any signs of occlusion, clotting, or 
ischemia, for up to one month. After 2 and 4 weeks following implantation, the grafts and 
adjacent native blood vessels were harvested for histological evaluation with explants assessed at 
2- and 4-week time points in longitudinal and cross-sections using H&E staining as well as 
markers for endothelial and smooth muscle cells (ECs, SMCs) to assess gross morphology, cell 
ingrowth and proliferation, and the cell phenotypes within the graft (Fig VI-4).  The ability of 
the lyophilized silk tubes to remain patent over 2- and 4-week time points is particularly 
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encouraging, given that small diameter ePTFE tubes implanted in parallel exhibited occlusion 
within 24 hours. 
 
Figure VI-3. characterization of vascular cell response to materials in vitro. (a) endothelial 
and smooth muscle cell attachment after overnight incubation. (B) Images of HUVECs and 
SMCs on silk, collagen and PTFE films as well as tissue culture plastic (TCP) after overnight 
incubation. (c) smooth muscle cell proliferation over two weeks. (D) endothelial cell 
proliferation over a period of two weeks 
Preliminary results with the implanted silk tubes indicate that ECs and SMCs migrated 
into the tubes and proliferated in the lumen, while maintaining patency over a period of at least 4 
weeks, the end point of the study. Evidence of neointimal hyperplasia and confluent endothelium 
was seen by the smooth muscle actin (SMA) and factor VIII staining (Fig VI-4). Graft cellularity 
increased with time of study, suggesting the progressive migration of SMCs and ECs from the 
native aorta (Fig VI-5).  Cells proliferated throughout the length of the silk graft and were 
adherent to the walls of the tube as observed at time of harvest, only dislodging during 
histological sectioning.  However, the fact that the detachment occurred only near the center of 
the graft suggests that the cellular remodeling of the vessel remains incomplete at 4 weeks, and 
cellular detachment may be resolved with further migration, proliferation, and remodeling at 
longer time points.  It is especially interesting that the silk tubes remained patent without any 
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special modifications or incorporation of drugs.  Potential SMC hyperproliferation over longer 
times, however, may necessitate stricter control over the properties of the silk tube, in particular 
through the incorporation of paclitaxel, a cytotoxic compound that induces nearly complete 
inhibition of SMC proliferation, into the spinning process 
 
Figure VI-4. histology of silk tube graft 2 weeks and 4 weeks post-implantation. Full cross-
sections were taken at 2 weeks and 4 weeks post-implant for the native aorta (section 1, close to 
the interface with the silk tube) and at two different positions along the implanted silk tube graft 
(section 2 and section 3), as shown on the schematics. Blood flow is from left to right. adjacent 
histological sections were stained for hematoxilin and eosin (H&E), smooth muscle actin (SMA) 
and Factor VIII at both time points. all images are shown in low and high magnification. after 2 
weeks, silk grafts were patent with evidence of neointimal hyperplasia (see 2-week histologies of 
section 2) and a confluent endothelium (see 2-week histologies of section 3). after 4 weeks, these 
changes were less pronounced and tissue remodeling has taken place (see 4-week histologies of 
sections 2 and 3). all scale bars are 200 μm141, 142. 
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Figure VI-5. H&E, SMA, and Factor VIII of explanted vessels 
 
DISCUSSION 
Small diameter silk tubes offer great promise as a vascular graft and are a good 
alternative to existing methodologies.  Through the use of a natural biopolymer, silk fibroin, and 
a gel spinning technique, vascular grafts may be produced with precise control over dimensions, 
mechanical properties, and drug loading and release.  This approach represents an improvement 
over synthetic-based grafts in terms of biodegradability, vascular cell remodeling, and control of 
material deposition and function (chemical and mechanical).  Compared to PTFE, silk fibroin is 
comparable in terms of thrombogenicity, as determined by protein adsorption and platelet 
adhesion, and demonstrates an improved vascular cell response.  This vascular cell remodeling 
component was likewise observed in rat studies in vivo, as smooth muscle and endothelial cells 
migrated into and proliferated within the silk grafts, producing a confluent endothelium, a critical 
barrier to thrombosis.  These results are contrasted with those of ePTFE tubes, which exhibited 
thrombosis and were occluded within days. 
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While these results are promising, future work will focus on additional modifications to 
improve tube mechanics and vascular cell response.  In terms of mechanics, different winding 
patterns or composite tubes may be generated using the gel spinning process to control issues 
such as differences in compliance at the sites of anastomosis, radial distension, degradation rate, 
and overall strength. In addition, silk grafts may be produced both with and without vascular 
pharmaceuticals such as paclitaxel, a cytotoxic compound commonly used in drug-loaded stents 
that in low doses results in a nearly complete inhibition of vascular smooth muscle cell 
proliferation.  This would provide more control over the vascular cell response, in vitro and in 




Aim 5: Tissue Function: Hierarchically Designed Blood Vessels 
INTRODUCTION 
Cardiac tissue engineering aims to generate a functional piece of cardiac tissue in vitro, 
that has capability to regenerate the injured myocardium. While advances have been made in 
guiding cardiomyocytes to assemble into functional contractile tissues
8
 the size of engineered 
tissues has been limited by the diffusional penetration depth for transport of nutrients, and most 
critically oxygen. Perfusion studies have demonstrated that fluid flow through cardiac constructs 
in vitro improves cell viability and function, however there are still no systems that enable an 
immediate establishment of such perfusion in vivo
153, 154
. 
We propose to generate a vascular tree that mimics native blood vessels, and engineer a 
perfusable cardiac graft that can be readily implanted onto injured myocardium. Vascular tree 
will be formed in a hydrogel patch using microfabrocation technology, in a way that enables 
population of hydrogel with cardiac precursor cells forming synchronously contractile cardiac 
muscle. Biophysical cues of pulsatile fluid flow and angiogenic cytokines will be used to induce 
vascular maturation. To demonstrate in vivo functionality, the vascularized cardiac graft will be 
tested using a rat abdominal aorta model. We hope that this microfluidic approach to designing 
blood vessel networks will enable creation of larger scale cardiac grafts which could be used to 
treat the huge burden of heart disease in America. 
 
Perfusion Systems for Cardiac Tissue Engineering 
The size scale of statically grown cardiac tissue has been limited to a viable cell layer of 
approximately 200 µm, a value corresponding to the diffusional penetration depth of oxygen
155
. 
While there have been attempts to enhance nutrient transport using bioreactors with mixing of 




Perfusion systems have been successfully used to enhance oxygen transport through 
constructs, but direct exposure to shear stress generally had negative impact on 
cardiomyocytes
157
. To provide oxygen transport in a more physiological manner, our laboratory 
has developed a channeled scaffold made of a biocompatible elastomer. Channels were designed 
to enable medium flow and supply of oxygen over short distances, while protecting 
cardiomyocytes within the scaffold pores from direct shear, thus providing oxygen transport in a 
way similar to that in native tissue. Perfusion led to an increased viability of cardiomyocytes 
throughout the scaffold volume. The optimal flow rate was determined to be 1mm/s, a linear 
velocity that correlates to that in vivo
153
. 
Perfusion studies validated the hypothesis that physiological-like oxygen transport can 
enhance the performance of the engineered cardiac constructs. However, a limitation of this 
design is that the tissue is supported only inside the bioreactor. Following implantation, it would 
no longer be perfused and the cells beyond the diffusional limit would die within a relatively 
short period of time. This limitation inspired the proposed work to engineer a directly perfusable 
cardiac constructs, by forming an internal network of blood vessels that can be connected to the 
vascular supply of the host. 
 
MATERIALS AND METHODS 
SU-8 Patterning 
Poly(dimethylsiloxane) (PDMS; Fisher) molds were prepared using standard soft 
lithography. AutoCAD (Autodesk) was used to design the masks that (Cad/Art Services), and 
SU-8 (Microchem) photolithography was used to generate master molds. The vessel designs 
were limited by space constraint due to the surgical model, as well as regular branching patterns 
designed through geometric analysis of tessellating patterns. 
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Fibrin Vessel Gelation 
Gelatin was used as a sacrificial element in fabricating the vessels. A saturated solution 
50%w/v of Gelatin (difco) was made with boiling PBS, and loaded into the PDMS relief mold. It 
was then cooled to allow for gelation and peeled from the PDMS master. A 15% w/v solution of 
Fibrinogen (Sigma) with Thrombin (sigma) at 10U/ml was then pipetted surrounding the cooled 
gelatin cast and allowed to form a gel for 20 min. The ends of the vascular pattern were then 
exposed and the entire graft was placed at 37 degrees and the gelatin material was melted out. 
 
Gelatin Methacrylate Method 
Gelatin methacrylate (GelMA), a collagen-based hydrogel, was a fully tunable material 
synthesized to replace fibrin as the scaffold material. Gelatin methacrylate could be incorporated 
with non-biofouling elements such as polyethylene glycol (PEG) to further increase the 
biological compatibility with blood. We used soft lithography to generate master molds for the 
vessel constructs. The patterns of vessels ranged from repeating tesselations with a stepwise 
increase in the number of vessel branches (and therefore a stepwise decrease in the flow rate) to 
a biomimetic vascular design (Fig VII-1). 
 
 
Figure VII-1. A subset of vessel designs developed. The ends of each vessel are approximately 
800 µm, with branches down to 50 µm. Scale bar = 5 mm. 
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Seeding Cells 
Human smooth muscle cells (HSMC), human umbilical vein endothelial cells (HUVECs) 
were used to line the vessel networks.  Culture conditions were the same as methods used in 
chapter VI. To evenly seed the cells, multiple seeding steps were used, rotating the graft between 
seeding events to ensure complete lining of the vessel. 
 
Perfusion 
Diaphragm pumps (Parker Hargraves) were used to simulate pulsatile blood flow. 
Acellular grafts were perfused with dyes, fluorescein or trypan blue to validate the path of fluid 
flow, and check for potential leaks in the graft. Cellularized vascular grafts were connected to 
barb adapters and exposed to pulsatile fluid flow for two weeks. 
To enable physiologic pulsatile pressure to be run through the vessel grafts we fabricated, 
a novel bioreactor was designed and made using SolidWorks and standard milling techniques. 
However, to enable prescise control over the pressure, which we hypothesized to be critically 
important for the maturation of the vessels, a microcontroller chip was also incorporated with 
pressure sensors and a linear actuator to dynamically control pressure during the cultivation 
period. To validate that the vessel material was amenable to cells viability, mesenchymal stem 
cells were loaded into the fibrin or GelMA phase of the vascular networks and were perfused. 
 
RESULTS 
Microfluidics and Vascular Networks 
Microfludic technologies can utilize soft lithography to generate fluid networks with 
micrometer-level precision. Depending on fabrication requirements, essentially any enclosed 
geometric design in two dimensions can be fabricated into a fluid network. We have shown that 
using biocompatible materials (e.g., polyethyleneglycol
158
) complex branching patterns can be 
formed despite the relative softness of the material in comparison to polydimethylsiloxane 
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(PDMS). Multiple groups have shown that microfluidics can be made to mimic vessel 
geometries
159
 however most approaches have been limited by the use of PDMS, which does not 
degrade in vivo, nor does support cell growth. Microfluidic technologies thus provide the basic 
tools necessary to create blood vessels, but appropriate materials, such as biocompatible and 
degradable hydrogels still need to be implemented for in vivo applications. 
We used our expertise with microfluidic fabrication and obtained preliminary results 
demonstrating the feasability of making microchanneled networks within a fibrin gel. Fig VII-
2A shows two photolithographic masks network geometries of different branching complexity. 
These designs were chosen due to their size scales relative to the rat abdominal aorta (1 mm), an 
implantation model already developed in our lab for testing of cardiovascular grafts. Using the 
sacrificial gelatin approach shown step-by-step in the schematic in Fig VII-4, fibrin networks 
were made which were cannulated at both ends and perfused under physiologic flowrates (Fig 
VII-2B). using a pulsatile diaphram pump. These fibrin networks are highly cell compatible; 
endothelial cells were seeded on the surface forming a confluent cell layer as can be seen by live-
dead staining in Fig VII-2C. These preliminary results provided us a proof-of-principle evidence 
generating microvascular networks within a biocompatible hydrogel capable of in vitro 




Figure VII-2 Branching Vascular Networks (A,B) Example geometries of photolithographic 
masks to generate PDMS templates. (B) Trypan blue dye was perfused through a fibrin graft of 
branching geometry found in (A). (C) Live dead of endothelial cells seeded within the fibrin 
graft showing confluent endothelial cell layer formation. Channel width is 500 µm. 
The initial choice of design for the vascular geometries will be based on previous 
perfusion results and modeling for transport boundaries
160
. Initially, a smaller number of 
branches will be used, with two geometries shown in Fig VII-2. The channels will start at a 
diameter of 1mm (the size of the rat abdominal aorta) and branch down to smaller vessels that 
are approximately 100 µm in diameter (Fig VII-2A). Warm gelatin solution will be casted into 
the PDMS patterns, serving as a relief mold. The PDMS will then be peeled away after the 
gelatin cools and stiffens. The actual vascular scaffold material, fibrinogen, will then be molded 
around the gelatin in one homogenous phase, providing uniform mechanical strength. This 
approach differs from other lithographic approaches, which utilize layer-by-layer assembly and 
have inherent limitation of weak connection between layers, a key plane for fracture and failure, 






Figure 2. Branching Vascular Networks  (A,B) Example geometries of 
photolithographic masks to generate PDMS templates.
(B) Trypan blue dye was perfused through a fibrin graft of branching 
geo t  f  i  ( ). (C) Live dea  of en lial lls eded within 
the fibrin graft sh wing onflu nt endothelial cell layer formation. 
Channel width is 500um.
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Figure VII-3. Schematic of the stepwise approach used to generate vascular networks with 
cardiac tissue. Gelatin is casted into the mold (2), followed by mold removal (3) and subsequent 
encapsulation of fibrin gel (4). The gelatin layer is melted away leaving a hollow network for 
fluid flow (5). Cardiac tissue constructs are added (6). 
Fibrinogen is precipitated by the enzymatic activity of thrombin and is easy and quick to 
gel, while being kept at physiological conditions. Material properties of this hydrogel scaffold 
can be tuned by usage of Factor 13, which crosslinks the precipitated fibrin and increases its 
mechanical strength. While the initial choice of material has been fibrin for its biocompatibility 
and broad clinical use, other materials could also be used in future, such as gelatin methacrylate 
which has a wider range of material mechanical properties, but utilizes UV light. We also have 
PDMS is fabricated
Gelatin is cast
PDMS mold is removed
Fibrin vasculature is formed
Gelatin is melted away







Figure 4. Schematic of  the stepwise approach used to generate vascular networks with cardiac tissue. Gelatin is casted 
into the mold (2), followed by mold removal (3) and subsequent encapsulation by f ibrin gel(4). The gelatin layer is 
melted away leaving a hollow network for f luid f low (5). Cardiac tissue constructs are added (6). 
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excellent experience with silk fibroin scaffolds that can be fabricated both as solid porous shapes 
and as hydrogels. 
The hydrogel assembly will then be placed at 37 degrees, causing the gelatin to melt 
away, and leaving the hollow microfluidic network behind. After successful generation of the 
hollow vascular network, the cardiac phase of the graft will be made surrounding the vessels, by 
an approach in routine use in our laboratory. For these experiments, we plan to use rat neonatal 
cardiomyocytes due to the consistency of their cardiac phenotype and to enable implantation into 
syngeneic rat. The entire fabrication process is outlined in the schematic (Fig VII-3). 
 
Biophysical Cues 
We hypothesize that the microfabricated vascular network will need additional 
biophysical cues to fully mature and be functional in vivo. The in vivo environment will generate 
a large amount of hydrodynamic shear and cyclical pressure to which the cells need to be 
acclimated. Previous work has shown that pulsatile flow is critical in forming thick and 
mechanically robust blood vessels
21
. As such, pressure controlled flow loop bioreactor was 
fabricated (Figure VII-4). A housing bath for the vessel network allowed the connection of each 
end of the network to perfusion tubing. Flow was generated by a peristaltic pump capable of 
pushing against pressures in physiologic range. A linear actuator clamping the distal tubing was 
controlled by an Arduino, which had inputs from pressure sensors on either end of the vessel 
network. This feedback loop was therefore designed to precisely control the pressure drop across 
the vessel network, where pressures could increase and decrease in a predictable and cyclical 
manner, thus creating pulsatile physiologic flow. This perfusion loop is fully programmable, 
allowing the generation of pressure-based maturation procedures. A matured blood vessel can be 
easily disconnected from the bioreactor and used for implantation. Figure VII-5 demonstrates an 
example of perfusion through the vascular network using a Trypan Blue dye, showing the 




Figure VII-4. Schematic of vessel reactor with bioreactor control housing and mechanism 
 
 
Figure VII-5. Fabricated bioreactor with and without pulsatile flow, as evidenced by tracer dye 
through the microvascular network. 
 
While microfluidic technology allows exquisite precision of the network geometries, it is 
limited to 100 µm resolution for soft hydrogel materials. To induce further capillary branching, 
needed to deliver nutrients on the individual cell scale, controlled release VEGF and PDGF will 
be emplyed to induce and stabilize capillary network formation (Fig VII-6A). We plan to use 
poly(lactic-co-glycolic) acid (PLGA) microspheres (Fig VII-6B), as in our previous studies, to 
maintain gradual release of these factors into the vascular hydrogel and promote capillary 
sprouting
161
. As shown by the release kinetics of FITC dextran (Fig VII-6C), release was 
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maintained over a one month period. The microspheres can be directly incorporated into the 
formation of the cardiac tissue phase to promote angiogenesis from the vascular network to the 
cardiomyocytes. The cytokines are initially encapsulated within the microspheres using a double 
emulsion technique and are released when the PLGA microspheres degrade
162
.  The rate of 
degradation can be easily tuned by changing the ratio of the lactic to glycolic amounts in the 
polymer, to provide temporal control over the VEGF signaling. 
 
 
Figure VII-6. Vessel maturation. (A) schematically depicts vessel changes with stimulation 
conditions, left to right, with cells, with perfusion for increased cell layer thickness, perfusion 
and microspheres to promote angiogenesis. (B) SEM of PLGA microspheres. (C) controlled 
release of FITC dextrans, 40kDa ~to VEGF mw, showing percent of VEGF released over one 
month. 
Cellular Ingrowth: Histology 
To demonstrate cellularity within the fabricated graft, a vessel network shown in Figure 
VII-7 was created with smooth muscle cells incorporated into the fibrin phase. This was cultured 

















Cumulative Dex40-FITC release from MS
Initial seeding Perfusion Perfusion + Microspheres
A
B C
Figure 5. Vessel maturation. (A) schematically depicts vessel changes with stimulation 
conditions, lef t to right, with cells, wit  perfusion for increased cell lay r thickness, 
perfusion and microspheres to promote angiogenesis. (B) SEM of  PLGA microspheres. 
(C) Controlled release of  FITC dextrans, 40kDa ~to VEGF mw, showing percent of  
VEGF released v r o e month. 
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and organization. The cross sections shown in Fig VII-7 are sequentially organized and verify 
the branching architecture of the vascular network throughout the culture period. It clearly begins 
with a single inlet, branches to two separate channels, then 4 channels and reduces back to a 
single outlet.  Cells can be seen throughout each of the cross sections, therefore the diffusive 
capacity of the hydrogel can support cell growth and proliferation. Interestingly the cells seemed 




Figure VII-7. Cells cultured for 2 weeks in fibrin graft. These H&E crosssections show the 
cellularity and patency of the vessel networks after 2 weeks on the bioreactor system. The 
sections in the top panel are sequential through the graft. 
In vivo Testing 
In vivo testing is critical for demonstrating the stringent requirements for tissue 
engineered constructs, including in particular hemocompatibility, patency, viability and 
mechanical fucntion. As an initial model we decided to use a model of the rat abdominal aorta, 
established in our laboratory, to surgically anstomose vascularized cardiac constructs. A rat 
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model was chosen as a compromise between the expense of using a large animal cardiac model 
and the surgical practicality of a mouse model. The rat abdominal aorta has a diameter of 
approximately 1mm, and the abdomen can accommodate the addition of tissue volume. Because 
the surgical site is infrarenal, there is a high survival rate and intubation is not necessary. The 
abdomen is also amenable to many types of non-invasive imaging for continuous monitoring of 
the implanted grafts. 
 
 
Figure VII-8. Abdominal Aorta Implantation of Vascular Network. (A) Arrow indicates 
abdominal aorta location in the dissected cavity. (B) The aortic blood flow is then halted using 
micro clips, and the aorta is transected. (C) The vascular graft is then sutured as an interposition 
graft, this image showing slow blood flow through the fibrin graft. 
The surgical procedure (using an active IACUC protocol) involves a midline laparotomy 
and dissection of the abdominal aorta from the inferior vena cava (Fig VII-8A). Upon successful 
separation, the animals are heparinized (50 U/kg), the aorta is clamped using microvascular 
vessel clips and transected (Fig VII-8B). The graft is then sutured in an interposition direct end-
to-end anastomosis (Fig VII-8C). A direct interposition decreases the likelihood of thrombosis 
in comparison to a side to side bypass procedure. Approximately 12, 8-0 prolene sutures are 












Figure 6. Abdominal Aorta Implantation of Vascular Network. (A) Arrow indicates abdominal aorta 
location in the dissected cavity. (B) The aortic bloodflow is then halted using micro clips, and the 
aorta is transected. (C) The vascular graft is then sutured as an interposition graft, this image 
showing slow blood flow through the fibrin graft with geometry found in figure 3A 
A B C
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under a microscope to enhance spatial uniformity of suture placement. To assess acute patency, a 
blanching flow-no flow test will be performed to allow visual inspection of perfusion. 
 
Doppler 
To assess function over a two week time period, Doppler ultrasound measurements were 
conducted (Fig VII-9). The left panel shows the linear velocity of bloodflow through a sham rat, 
one which did not receive a branching vascular network. The rat on the right was implanted with 
a branching vascular graft and the linear velocity of the bloodflow through is approximately one 
fourth that of the sham rat, suggesting patent blood flow through all four channels, causing a 
proportional decrease in linear velocity. This provides evidence that the grafts maintained 
patency in vivo and were properly branched. 
 
 
Figure VII-9. Ultrasound data showing patency of blood flow through a sham rat (left) and a rat 
with a vessel network which branches into 4 equally sized conduits, which show one fourth the 
linear fluid velocity 
We plan on weekly sacrificial time points to study graft integration over time, and expect 
full integration by 4 weeks based on our previous experience with the tubular silk graft. To 
monitor the graft outside the designated sacrifice times, Doppler ultrasound will be used to 
determine flow rates through the network non-invasively. At each time point we will perform 
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angiography to visualize the vascular tree geometry as well as explant the grafts to examine the 
cellular organization and survival of the cardiac graft.  
This approach combines the microfabrication approaches and resolution with surgical 
expertise and design considerations to create a fully functional and designable vascular tree, 





Cardiac disease remains one of the greatest health challenges today, with increasing 
global incidence and limited options available for curative therapy. Due to a limited capacity for 
self-renewal, cell based strategies for treating cardiac disease offer a unique opportunity to 
provide therapeutic benefit, but efforts have been limited due to maturity of cell source, 
organizational complexity and integration of grown tissues. Despite these obstacles, the field of 
tissue engineering holds the promise to build new cardiovascular tissues in vitro, and can 
leverage novel techniques and approaches to address the hurdles that need to be overcome. One 
such approach - microtechnologies, manipulation of the environment on the micron scale, can 
uniquely enable methods to study and build cardiac tissues. In this dissertation, the fields of 
cardiac tissue engineering and microtechnologies were used to investigate cardiovascular cell 
sources, to enable advanced organizational assembly of the tissue level microenvironment, and to 
build novel blood vessels with in vivo function and hierarchical design.  
Each of the aims used microtechnologies to study or build cardiac tissue. For aim 1, the 
microscale bioreactor was critical in screening the effects of electrical stimulation on the 
condition of hESC derived CMs. hESC differentiation is costly and electrical stimulation of 
hESC CMs was largely unknown, but the microbioreactor approach maximized the analytic 
potential of each cell, permitting multiple stimulation paradigms to be tested simultaneously. 
With the use of the high-throughput microbioreactor, electrical conditioning was shown to 
improve the contractile function of the hESC cardiomyoctes and could even condition their 
autonomous beating frequency, a phenomenon which may be utilized in the future to better 
match and train hESC cells for electrical integration with a patient’s heart.  
Aim 2 studied the angiogenic stabilizing capacity of different MSC populations. Despite 
classical identification of the various cell populations as MSCs through marker expression, 
functional differentiation, and morphology, only the bone marrow MSCs were able to stabilize 
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nascent vessels formed by HUVEC endothelial cells. This was shown using a microtechnology 
approach to spatially pattern the different cell types at varying distances from the nascent 
vessels, and their migration rates were determined. This assay provided a unique method to 
establish a chemoattractive effect of the endothelial cells on the bone marrow MSCs. The 
identification of these cells, with an enhanced mural phenotype compared with other MSCs may 
dictate the cell populations used to build microvascular networks and blood vessels grown in 
vitro.  
Figure VII-1 Diagram of dissertation approach and studies. The top show representations of the 
two fields, cardiac tissue engineering and microtechnologies, and the bottom show as  icons the 5 
aims which were developed and explored in this dissertation. 
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 With the identification of two cardiovascular cell sources aim 3 focused on 
developing a method to organize the complex microenvironment and mimic the organizational 
complexity of cardiac tissue. A robust system was developed which could recapitulate the 
intricate spatial arrangement of any number of cell, cytokine or drugs over the 
microenvironmental scale. Tissues have stereotyped architecture, and the micromolding 
approach enables highly specific organization of numerous elements using hydrogel building 
blocks. This was utilized to further develop a model of MSC migration, where cell trajectories 
and spatial distributions could be predicted using two driving forces similar to dipole electric 
fields. Therefore a novel platform for fabricating complex tissues was developed, which can be 
used to mimic many unique aspects of the tissue microenvironment.  
One key aspect of ischemic heart disease is generally the presence of coronary artery 
disease, the gradual narrowing of the vessel lumen due to atherosclerotic plaque. These vessels 
are small, only a few millimeters in diameter. Therefore a textile winding approach developed in 
aim 4, using micro-sized strands of a novel biomaterial silk, engendered a new small diameter 
blood vessel surrogate. The winding approach permits a high degree of tunability, weaving 
different potential strands to change the overall composition, modifying release of drugs, or 
degradation rates. The development of an acellular small diameter vessel graft has the potential 
to ameliorate cardiac disease through the possible replacement of diseased coronary arteries.  
With increasing tissue engineered construct size, transport limitations hinder the absolute 
size of tissue that can be grown in vitro. There is a gap in vascular tissue engineering, between 
the creation of stable and surgically amenable single vessel conduits and microvascular 
networks. Therefore in aim 5, microtechnologies were used to build a hierarchically branching 
vascular network that retained the single vessel surgical capabilities, but also allowed for 
microvascular networks to be perfused within the same overall fluid network. This design and 
microfabrication approach uniquely fulfills the gap in functional vascular tissue engineering, by 
providing nutrient and waste transport to individual cells through a branching vascular tree 
which can be surgically implanted and connected to the host vasculature.  
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 Cardiovascular disease will play an ever increasing role in healthcare in the 
future, and cardiovascular tissue engineering has the promise to address the specific needs 
currently unmet by present therapies. Using microtechnolgies, this dissertation has demonstrated 
the ability to study and create cardiac tissues, over multiple scales, from identification of novel 
signals and systems to identify potential cardiovascular cell sources, methods to recapitulate the 
complexity of the cell microenvironment and the creation of novel vascular networks. This 
approach of manipulation of cells over the micron scale enables engineering design to overcome 
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